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Maternal substance misuse/abuse during pregnancy may lead to adverse neonatal outcomes, 
including neonatal abstinence syndrome (NAS). NAS is a constellation of withdrawal symptoms 
exhibited in newborns in response to the discontinuance of in-utero exposure to licit and illicit 
substances. The incidence of NAS is directly related to the increasing rates of maternal substance 
use/abuse. The United States has experienced a five-fold increase of newborns born with NAS. 
The care of the newborn with NAS is one of the most challenging conditions for the neonatal 
nurse. Management of newborns with NAS requires knowledge that has not been traditionally 
partnered within care of the neonatal intensive care unit (NICU) but rather more often in the 
newborn nursery. And thus, understanding addiction, addictive behaviors and the psychological 
needs of substance misusing/abusing parents have not been common place in all NICU settings. 
Caring for the newborn with NAS and interacting with the addicted parent and parents may 
present ethical and moral dilemmas for the neonatal nurse. This pilot study explored the presence 
of moral distress among neonatal nurse caring for the newborn with NAS whose mothers used 
illicit substances during pregnancy. A descriptive study engaged neonatal nurses from a Level III 
NICU in completing the Moral Distress Scale Pediatric version. Frequency and intensity of 
moral distress among the sample assisted in determining the presence and levels of moral 
distress. Neonatal nurses caring for newborns with NAS whose mothers used illicit substances 
during pregnancy experienced varying degrees moral distress.  
  
Valarie Ann Artigas – University of Connecticut, 2017 
The results of this research study revealed that indeed, neonatal nurses experience moral distress 
to varying degrees within the NICU setting. Caring for newborns with NAS within this sample 
participant group produced moral distress especially when these nurses interacted with substance 
misusing mothers and care givers. Although not all neonatal nurses caring for newborns with 
NAS and/or interacting with substance misusing care givers experienced moral distress the 
review of the data is imperative for identifying strategies to support nurses universally to 
prevent/address moral distress in the NICU. 
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CHAPTER ONE: INTRODUCTION 
In 2013, according to the survey sponsored by the Substance Abuse and Mental Health 
Services Administration an estimated 24.6 million Americans age 12 or older were current illicit 
drug users. This estimate represents 9.4% of the American population aged 12 or older. Illicit 
drugs include marijuana, crack/cocaine, heroin, hallucinogens, inhalants, and prescription-type 
grouped psychotherapeutics. Prescription type psychotherapeutics used for non-medical 
therapies include pain relievers, tranquilizers, stimulants, and sedatives. The current rate of illicit 
drug use among Americans is on the rise and has become a national health concern. 
 Prescription drug use and use of illicit drugs by pregnant women is reaching epidemic 
portions in the United States according to data collected from the National Survey on Drug Use 
and Health/National Institute on Drug Abuse in 2013. Substance use during pregnancy is 
associated with birth defects, low birth weight, premature birth, neonatal abstinence syndrome 
(NAS), seizures, alterations in brain organization, and neurobehavioral/cognitive deficits (Bada 
et al., 2005; Hudak & Tan, 2012). Cases of NAS, which is a group of problems that occur in 
newborns exposed to prescription pain killers or other drugs during fetal development grew by 
almost 300% in the United States from 2000 to 2009 (Hayes & Brown, 2012). Studies between 
2000 and 2009 revealed U.S. trends identifying the annual rate of NAS diagnosis for the 
newborn population has increased approximately three-fold and maternal opiate use increased by 
almost five-fold (Patrick et al., 2012). In the United States one newborn is born every 25 minutes 
who will experience NAS (Patrick, Davis, Lehmann, & Cooper, 2015). 
Substance Use During Pregnancy 
Substance use during pregnancy with prescribed pain medications, illicit drugs and 
selective serotonin reuptake inhibitors (SSRI) may affect the fetus and newborn adversely. 
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Common categories of drugs used by pregnant women include opioids, semisynthetic opioids, 
synthetic narcotics, central nervous system (CNS) depressants/stimulants, SSRIs, and 
hallucinogens (Hudak & Tan, 2012). 
The placenta is the functional unit between fetal blood and maternal blood. The function 
of the placenta includes nutrition, respiratory, metabolism, excretion, and endocrine activity to 
maintain fetal and maternal well-being. In order for a drug to produce a teratogenic or 
pharmacological effect on the fetus, it must cross from the maternal circulation to the fetal 
circulation through the placenta by diffusion. The rate of transfer depends on the chemical 
properties of the drug such as protein binding, pH differences, lipid solubility, and molecular 
weight of the drug. Only free unbound drugs cross the placenta. During pregnancy maternal 
plasma albumin decreases while fetal albumin increases. As a result, the concentration of free 
drug increases, increasing what crosses the placenta to reach the fetus.   
 Early in gestation, during the embryonic stage (conception to Week 10 of development), 
drugs may have significant teratogenic effects. However, during the fetal period (Week 10 to 
Week 40 of development and gestation), after major structural development is complete, drugs 
have more subtle effects, including abnormal growth and/or maturation, alterations in 
neurotransmitters and their receptors, and brain organization affecting cognitive and language 
function (Behnke & Smith, 2013). 
Other indirect effects of drugs of abuse on the fetus include altered delivery of substrate 
to the fetus for nutritional purposes, either because of placental insufficiency or altered maternal 
health behaviors attributable to the mother’s addiction. These altered behaviors, which include 
poor nutrition, decreased access and compliance with prenatal health care, exposure to violence 
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and neglect, maternal socioeconomic conditions, as well as increased risk of mental illness and 
infection, may place the fetus at risk.  
Many factors come into play within the clinical presentation of neonatal drug withdrawal. 
Newborns will exhibit symptoms of withdrawal based on the type of drug, timing and amount of 
the last maternal use, polysubstance use during pregnancy, and the metabolism and excretion of 
the drug from both maternal/neonatal systems. While NAS occurs in newborns predominantly 
exposed in utero in opioid dependent pregnant women, there are non-opioid drugs that may also 
cause withdrawal in the newborn (Kellogg, Rose, Harms, & Watson, 2010). Opioid dependence 
is seen with opiates, semisynthetic opiates and synthetic narcotics. Non-opioid drug classes 
include CNS depressants, CNS stimulants, and hallucinogens. SSRIs are commonly used for the 
management of depression and anxiety in pregnant women. SSRI use in the last trimester of 
pregnancy has been associated with symptoms in the newborn very similar to clinical signs of 
NAS (Alwan & Friedman, 2009; Galbally, Lewis, Lum, & Buist, 2009). “Designer” drugs 
commonly used by pregnant women include cocaine, marijuana, LSD, methamphetamines, and 
ecstasy. Depending on fetal exposure these newborns will exhibit temporary symptoms of 
withdrawal, which include irritability, tremor movements of their arms and legs, and short sleep 
patterns. 
Neonatal Abstinence Syndrome 
NAS was first identified in the late 1960s to early 1970s by Dr. Loretta Finnegan and 
colleagues in Philadelphia and by Dr. Phillip Lipsitz in New York. Each noted that newborns 
whose mothers used cocaine or illicit drugs behaved in a certain way after delivery. These 
newborns were noted to be “passively addicted” demonstrating physical characteristics of drug 
withdrawal. Both Dr. Finnegan and colleagues and Dr. Lipsitz developed withdrawal scoring 
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tools based on their research and observation of drug exposed newborns. These tools were 
developed to quantify the severity of withdrawal symptoms experienced by the newborn and 
would later lead to the identification of NAS (Finnegan, Kron, Connaughton, & Emich, 1975; 
Lipsitz, 1975). 
 NAS has been defined as a complex disorder, with a constellation of behavioral and 
physiological symptoms that are remarkably similar despite differences in properties of the 
substance used by the mother. NAS usually is seen with withdrawal from opioids such as heroin 
or methadone but other drug classes including but not limited to narcotics, benzodiazepines, 
barbiturates, and alcohol may also bring about symptoms of NAS. Onset is usually 2 to 3 days 
after birth with clinical manifestations presenting in 60 to 80% of infants exposed to heroin or 
methadone. Unfortunately, polydrug use among some expectant women makes it difficult for the 
neonatal caregiver to determine a given effect on the newborn.   
The symptoms of NAS may be seen in many of the drug classes described and are often 
over lapping. As mentioned earlier, the clinical presentation of the newborn is influenced by 
many factors, which include the type or types of drugs used during pregnancy, the timing and 
amount of the last ingestion by the mother, and the metabolism and clearance of the drug or 
drugs by the newborn. Some newborns depending on fetal exposure may begin to show signs of 
withdrawal immediately following birth or within the first 24 hours after delivery; seen with 
some barbiturates, heroin, and SSRIs, while other newborns may not exhibit signs of withdrawal 
until the third or fourth day of life, as seen with cocaine, methadone, and buprenorphine 
exposure (Hudak & Tan, 2012). 
Newborns exposed during fetal development to nicotine, alcohol or marijuana do not 
usually exhibit symptoms of NAS but rather they present with abnormal behaviors which 
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normalize over a period of time (D’Apolito & Hepworth, 2001; Pichini & Garcia-Algar, 2006). 
The normalization of behaviors is unlike newborns with NAS, where clinical symptoms of 
withdrawal escalate over time as the drug is metabolized and eliminated.    
Clinical manifestations of NAS include CNS disturbances, including seizures, 
gastrointestinal and metabolic signs (loose watery stools, diarrhea, and failure to thrive), and 
signs of autonomic disturbances (yawning, sneezing, and perfusion mottling). Neurobehavioral 
symptoms of infants with prenatal opiate exposure include excessive sucking, jitteriness, 
hypertonia, high pitched cry, difficulty being comforted, and irritability (Bandstra, Morrow, 
Mansoor, & Accornero, 2010). 
Care of the newborn with NAS includes nonpharamacologic and pharamacologic 
interventions. The nonpharamacologic therapies are used by parents, caregivers, and nursing 
staff to provide supportive care. Nonpharamcologic treatment includes a thorough evaluation of 
the newborn’s behaviors and responses to human interaction and their enviroment to determine 
the need for specific soothing techniques (Jansson & Velez, 2012). Some infants respond to 
supportive care measures and do not go on to require pharmamcologic support. Determination 
for inititation of a pharmacologic agent to ameliorate symptoms of withdrawal are based on the 
nurse’s “scoring” of the newborn. The most widely used NAS scoring tool used in the United 
States is the Finnegan tool (O’Grady, Hopewell, & White, 2009; Sakar & Donn, 2006).  
In 1990, Finnegan and Erhlich published the modififed Finnegan NAS Scoring Tool 
(FNAST). The FNAST identifies 21 withdrawal symptoms assessed by the bedside nurse every 3 
to 4 hours before feedings (Finnegan & Ehrlich, 1990). The FNAST quantifies the signs and 
symptoms observed in the drug exposed newborn and is used as adjunct to clinical decision 
making (Orlando, 2014). Not all newborns experiencing NAS will require treatment but all drug 
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exposed newborns require identification and frequent assessments by the bedside nurse.  
Threshold scores guide the clinician for initiating treatment for symptomatic newborns that are 
not responsive to supportive care measures. These serial assessments guide and determine 
efficacy of treatment for the newborns experiencing moderate to severe symptoms in relation to 
the disturbances of the central nervous system, vasomotor, metabolic, respiratory, and 
gastrointestinal systems. 
            Generally speaking, the FNAST scores recommend pharmacologic treatment when scores 
are 8 or greater after three consecutive assessments (Finnegan & Ehrlich, 1990). Scoring of the 
newborn is kinectic and somewhat subjective. The American Academy of Pediatrics (1998) 
suggested that some clinicians may view the length and complexity of the tool to be too 
cumbersome for routine care of all newborns identified to be at risk.   
The length of stay in mananging the newborn with NAS may range from several days to 
several weeks, even months. To be able to assess the need for starting pharmacologic therapy, for 
weaning therapy and subsequently for discontinuing therapy is based largely on the FNAST 
scores assigned by the neonatal nurse (D’Apolito, 2014). Accurate scoring guides the neonatal 
clinician in unnecessarily starting an agent that the newborn may not need or increasing therapy 
by the clinician when the newborn’s symptoms have not been captured. Because scoring by the 
neonatal nurse is paramount in assisting the clinician it is important that scores are accurate and 
reliable. Inaccurate scoring may lead to under or overtreatment of newborns affecting the length 
of stay in the neonatal intensive care unit (NICU) setting and the newborn’s well-being.  
  The total cost for caring for newborns with NAS across the United States in 2009 was 
estimated to be $720 million dollars (Patrick et al., 2012). Aggregate hospital charges increased 
to $1.5 billion with 81% attributed to state Medicaid programs in 2012 (Patrick et al., 2015). 
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Newborns who are scored accurately and appropriately will have their symptoms managed safely 
and possibly may be discharged earlier from the hospital setting (D’Apolito, 2014).   
Nursing Care of the NAS Newborn 
Many newborns with NAS are cared for by neonatal nurses. The newborn with NAS is 
typically full-term, or close to 40 weeks gestation, and requires management for NAS as an 
inpatient in the NICU. Nursing care of these newborns may be extremely complex, time-
consuming, as well as frustrating and stressful to the nurse because of the severity of symptoms 
and neurologic disorganization exhibited by the newborn (Murphy-Oikonen, Brownlee, 
Motelpare, & Gerlach, 2010). Neonatal nurses provide newborn care, assess the newborn, 
administer nonpharmacologic and pharmacologic agents when ordered, and try to comfort these 
newborns during the withdrawal. NAS care for the newborn includes the provision of a quiet, 
soothing environment/voices, rocking, frequent feedings, promotion of sleep cycles and human 
contact, most often soley provided by the neonatal nurse due to lack of parent visitation or 
participation of care. The lack of visiting and participation in care is a frequent occurrence in 
these socially complex family situations in which mothers suffer from addiction.  
 Nursing management of NAS requires knowledge not traditionally associated with the 
NICU, such as addiction behaviors, social risk factors, and psychosocial needs of parents with 
substance abuse or addictive complexitites (Maguire, 2014; Sakar & Donn, 2006). When 
mothers do not actively partake and visit their newborns the neonatal nurse in addition to her 
nursing obligations of care incorporates her role to provide the care giver responsibilitites and 
mothers’ the newborn (Velez & Jansson, 2008). The absence of the mother, the newborn’s 
withdrawal symptoms and complexity of care may cause distress, frustration, and moral 
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dilemmas for the neonatal nurse (Fraser, Barnes, Biggs, & Kain, 2007; Murphy-Oikonen et al., 
2010).  
Moral Distress in Nursing 
 Research from the early to mid-1990s explored nurses’ attitudes and knowledge 
regarding addiction but did not explore the presence of moral distress. Critical emerging themes 
identified by those researchers regarding nurses’ responses included lack of knowledge regarding 
addiction, counterproductive attitudes when caring for addicted patients or while interacting with 
family members of the addicted patients and feelings of moralistic stress regarding addiction to 
the degree that some nurses would avoid contact with those patients (French, Pituch, Brandt, & 
Pohorecki, 1998; Ludwig, Marecki, Woolridge, & Sherman, 1996; Raeside, 2003). 
 In light of the current surge in numbers of newborns with NAS cared for in the NICU it 
is important for researchers to understand how neonatal nurses feel, as well as react and interact 
with the newborns with NAS and parents. Recent studies have indicated that there are strained 
relationships between the neonatal nurse and the addicted mother (Fraser et al., 2007; Maguire, 
Webb, Passmore, & Cline, 2012; Murphy-Oikonen et al., 2010). In all of these studies neonatal 
nurses expressed genuine caring towards these newborns and their desire to provide quality care 
to the newborns during their withdrawal, but expressed frustration and moral distress when they 
were not able to console or comfort the newborn. Other themes which were identified by the 
participants included beliefs that newborns with NAS did not need specialized care in the NICU 
and that the environment is too busy as well as overstimulating for those newborns. Some nurses 
verbalized their beliefs that newborns with NAS are not sick enough to warrant critical care as 
well as the frustration they felt when the babies were inconsolable with high pitched crying 
(Murphy-Oikonen et al., 2010). 
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 Maguire et al. (2010) noted that nurses were concerned with the mother’s ability to cope 
and care for their irritable newborn after discharge as well as acknowledged feelings of 
negatively judging the addicted mother; as well as some of the neonatal nurses’ demonstrated 
anger towards the mother for causing their infant’s withdrawal. In a study by Cleveland and 
Bonugli in 2014, the experiences by mothers of infants in the NICU with NAS validated the 
neonatal nurses’ perceptions, frustration, attitudes, and lack of knowledge about addiction, which 
can potentially lead to moral distress in the neonatal nurse. Recurring themes for these mothers 
included feeling judged, not being seen as a human being because of their addiction, and not 
being acknowledged as the mother who wants to share in caring for her newborn. 
Interestingly, another theme that surfaced was the perception of the mothers that there 
was variability from nurse to nurse in how their newborns were scored. Some mothers felt that if 
they had a good rapport with the neonatal nurse the infant had lower scores and when they 
perceived the negativity of the nurse their infant had higher scores. As previously mentioned, 
consistency among scorers guides the clinician for initiating, weaning, and the discontinuance of 
pharmacologic therapy. 
The principal investigator for the study postulated that NICU nurses caring for newborns 
with NAS may experience moral distress. The study warranted investigation to ensure 
consistency of care of the newborn with NAS, as well as to examine and promote the mental and 
physical well-being of the neonatal nurse. 
Early Identification of Moral Distress in Nursing 
The term moral distress among nurses was first identified by the original work from the 
philosopher Andrew Jameton in 1984. Moral distress may be experienced when a professional 
nurse is aware of and recognizes the right course of action but is unable to act upon that action 
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that is morally correct due to perceived or actual barriers such as lack of time, lack of 
organizational/physician support, unrealistic patient/family preferences, and legal boundaries 
(Jameton, 1993). Nurses are ethically obligated to protect patients from harm, and to advocate 
for and provide safe and appropriate care. When nurses are unable to provide the ethical tenets of 
the profession, they experience moral distress (Corley, 2002).   
 Research has identified that moral distress is more prevalent among nurses that practice 
in critical care in adult, pediatric, and neonatal settings. The presence of moral distress is evident 
secondary to critical illness of the patient, end-of-life care decisions, and self-reflection when the 
nurse perceives care or a clinical situation to be morally distressing (Corley, Minick, Elswick, & 
Jacobs, 2005; Elpern, Covert, & Kleinpell, 2005; Epstein & Delgado, 2010). Moral distress may 
lead to physical, psychological, and social difficulties experienced by the professional nurse 
(Cavaliere, Daly, Dowling, & Montgomery, 2010). Moral distress may lead to professional 
burnout as well as the nurse avoiding situations or family members that are the impetus to his/her 
perception of moral distress. When moral distress is experienced by a nurse he/she may 
withdraw from engagement with the patient, or provide a lower level of care which directly 
effects quality of care and patient satisfaction (Gutierrez, 2005; Hamric & Blackhall, 2007; 
Zuzelo, 2007). 
Moral Distress Among Neonatal Nurses 
The NICU often has frequent clinical scenarios in which moral distress may develop. The 
NICU is an environment requiring highly skilled neonatal nurses with critical assessment 
knowledge that compliments the technological and specialized equipment in order to care for the 
critically ill neonate. At times neonates may have uncertain or poor prognoses secondary to the 
fragility of life or congenital conditions. Moral distress may occur in neonatal nurses when 
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he/she has to perform procedures they are opposed to because they are aware that the neonate 
will experience pain or discomfort as well as give the parents false hope for treatment success 
(Tiedje, 2000). Moral distress is also experienced by neonatal nurses when curative care is futile 
and transitions to palliative care may be considered more appropriate (Cavinder, 2014). The 
degree and frequency of moral distress are dependent on characteristics of the clinical scenario, 
feelings of powerlessness and self-reflection of the nurse’s value system. If a nurse continues to 
experience moral distress without effective coping strategies, professional relationships, self-
esteem, and the quality of patient care may suffer (Cavaliere et al., 2010; Cavinder, 2014; 
Hamric & Blackhall, 2007). Caring for the newborn with NAS and interacting with the addicted 
maternal/paternal care giver may be perceived as a morally charged clinical scenario. 
Significance to Nursing Profession 
  The increase in substance use/abuse of expectant women predisposes them to risks for 
the pregnancy’s well-being, as well as the fetus’ and to the newborn after delivery. The poor 
health status and poor pregnancy outcomes in addicted women result in higher maternal/child 
and neonatal admissions involving high risk care/management. Newborns experiencing NAS 
require specialized care and longer hospitalizations.  
The FNAST is one of the most widely used scoring tools that provide a numeric value to 
a newborn’s withdrawal symptoms (Hudak & Tan, 2012). The challenge of using this tool or any 
other scoring tool is its’ subjectivity, therefore there may be difficulty in establishing consistency 
among the scorers (D’Apolito, 2014). Lack of consistency in scoring among the neonatal nurses 
may delay pharmacologic intervention or may not reflect that the newborn’s scores as 
diminishing versus escalating. Newborns that go on to require pharmacologic intervention to 
manage their withdrawal have longer hospitalizations and are separated from their mothers 
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which makes it difficult to establish attachment between the mother and infant dyad (Velez & 
Jansson, 2008). 
Moral distress in neonatal nurses occurs as a result of providing care for certain clinical 
conditions and patients. Caring for the newborn with NAS may cause moral distress in the NICU 
nurse. No research to date has sought to demonstrate the moral distress of neonatal nurses caring 
for these newborns. However, anecdotal comments and some limited data from other studies 
where this question has not been the focus have identified that indeed, neonatal nurses may 
experience moral distress when caring for the newborn with NAS (Fraser et al., 2007; Maguire et 
al., 2012; Murphy-Oikonen et al., 2010). It is important for neonatal researchers to identify the 
presence and level of moral distress experienced by the neonatal nurse. Identification may be the 
first step in preserving the self-integrity of the nurse as well as insure consistency when caring 
for the withdrawing newborn. 
Purpose of Study 
Neonatal nurses caring for newborns with NAS may experience moral distress to varying 
degrees (Maguire et al., 2012; Murphy-Oikonen et al., 2010). Moral distress may have negative 
effects on patient care and the well-being of nurses because of unresolved ethical conflict 
(Cavaliere et al., 2010; Janvier, Nadeau, Deschenes, Coutere, & Barrington, 2007). The purpose 
of this study was to explore whether moral distress occurs in neonatal nurses caring for newborns 
with NAS. 
Theoretical Framework 
The majority of research on moral distress has been explored among nurses working in 
adult intensive care units as well as palliative care units in both adult and neonatal settings. 
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Emerging research as previously discussed has identified moral distress among neonatal nurses 
caring for NAS newborns. 
Andrew Jameton (1984) was a pioneer researcher in identifying and addressing moral 
distress among nurses. He defined moral distress as painful feelings and/or the psychological 
disequilibrium that occurs when nurses are aware of the morally appropriate action required in a 
patient care situation, but cannot carry out the action because of institution or organizational 
barriers, lack of time, lack of nursing/medical leadership support, or policy or legal limitations. 
He later defined two types of moral distress: initial moral distress and reactive moral distress 
(Jameton, 1993). With initial distress, the nurse feels frustration, anger, or anxiety when faced 
with institutional or organizational obstacles and interpersonal conflict about values. Jameton 
goes on to define the occurrence of reactive distress as when a nurse cannot act upon her initial 
distress. 
Dr. Mary Corley also researched nurses in critical care setting in the mid-1990s regarding 
their perceptions of moral distress. Much of Dr. Corley’s work is similar to Jameton’s research 
of nursing and moral distress. Corley’s research became the foundation for her proposed theory 
of moral distress. Corley theorized that moral distress occurs among nurses when the nurse 
knows what is best for the patient but his/her course of action may conflict with the organization, 
his/her colleagues, the family structure or society as a whole. Therefore, moral distress occurs 
when nurses’ values and perceived obligations are not compatible with structural views or the 
work environment (Corley, 2002). Stated simply, Corley identifies the presence of moral distress 
when a nurse either is unable or perceives he/she is unable to advocate for his/her patient. Moral 
distress occurs as both an internal and external context. The external context includes the work 
environment, lack of leadership or physician support, and facility framework limitations. The 
  
14 
internal context of moral distress is related to the professional nurse’s psychological responses, 
for example, does the nurse develop feelings of low self-esteem, powerlessness to advocate for 
the patient, and has stress begun to affect his/her personal/professional life. Moral distress occurs 
when the nurse experiences feelings or perceives that his/her personal moral integrity is being 
threatened. Corley recognized that moral distress can be devastating to nurses leading to burn 
out, leaving the profession of nursing altogether and may have a negative impact on patient care. 
Corley’s theory is based on two foundations: (a) the science and art of nursing is one of a 
moral profession; and (b) nurses because of who they are, become moral agents (Corley, 2002). 
Written permission from Sage Publishing for use of the schematic representation of Corley’s 
theory reflective of her identified foundations is reflected in Appendix A. 
Corley, Elswick, Gorman, and Clor (2001) developed the Moral Distress Scale (MDS) to 
measure moral concepts. The guiding framework included Jameton’s conceptualization of moral 
distress, House and Rizzo’s role conflict theory, and Rokeach’s value theory (Corley et al., 
2001). Jameton’s conceptualization of moral distress was discussed earlier. Role conflict 
characterized by House and Rizzo (1972) identifies a type of stress nurses experience because 
they are held accountable to two different organizational authorities: their nursing manager and 
the medical providers who direct the provision of patient care. These authorities may impose 
conflicting expectations; subjecting the nurse to role conflict. Rokeach’s (1968) theoretical 
approach identified how a person’s values and value system may motivate an individual’s 
behavior Corley’s framework of moral distress guided this study addressing moral distress in the 
neonatal nurse caring for the newborn with NAS.   
  
15 
Research Question 
The following research question was addressed in this study: Do neonatal nurses 
experience moral distress when caring for newborns with NAS whose mothers used illicit 
substances during pregnancy? 
Definitions and Key Terms 
Conceptual definitions will be offered for the following terms: addiction, maternal 
addiction, and NAS. 
Conceptual Definitions 
Addiction is defined as a primary chronic disease of brain reward, motivation, memory, 
and related circuitry (American Society of Addiction Medicine, 2010). Dysfunction in these 
circuits leads to characteristic biological, psychological, social, and spiritual manifestations. Like 
other chronic conditions, addiction often involves cycles of relapse and remission. Without 
treatment or engagement in recovery activities, addiction is progressive and can result in 
disability or premature death. 
Maternal addiction occurs in substance dependent women. At the core of maternal 
addiction there is compulsive and uncontrollable drug craving, seeking and use. The mother 
loses the ability to control her life, rearranging her motivational priorities, and putting drug-
seeking and drug-taking behavior as a life priority at the expense of the most other activities, 
even when faced with negative consequences, such as the loss of child custody, or continuing use 
when the drugs do not produce pleasure effects (Hogan, 2007). 
Neonatal abstinence syndrome (NAS) is a constellation of signs and neurobehaviors 
experienced by the newborn that occur after abrupt discontinuation of in utero exposure to 
substances taken by the mother (Jansson & Velez, 2012). 
  
16 
Conceptual and Operational Definitions  
  Moral distress (conceptual definition) is defined by Corley as painful psychological 
disequilibrium that results from recognizing the ethically appropriate action, yet not taking it, 
because of such obstacles as lack of time, supervisory reluctance, an inhibiting medical power 
structure, institutional policy, or legal considerations (Corley, 1995). 
Moral distress (operational definition) for the purposes of the study explored nurses’ 
level of moral distress measured by Moral Distress Scale-R (MDS-R) pediatric version. The 
original moral distress scales were developed by Dr. Corley and colleagues and have been 
revised for use in non-critical care settings as well as among all members of the healthcare 
professional team (Hamric, Borchers, & Epstein, 2012). The MDS-R is a Likert-type scale. This 
scale measures frequency and intensity of moral distress and may be considered a single scale 
where scores from both frequency and intensity identify a single composite score to measure 
moral distress. 
Summary 
Neonatal nurses appreciate the epidemic surfacing in the United States from substance 
abuse/misuse. Substance use and abuse by pregnant women jeopardizes the pregnancy and the 
development and growth of the fetus. Newborns born to substance abusing mothers may develop 
NAS due to prenatal exposure. 
Newborns diagnosed with NAS may require pharmacologic therapy to manage the 
symptoms of withdrawal that are severe and do not respond to supportive care measures. 
Newborns requiring pharmacologic therapy are generally cared for in the NICU setting. Those 
newborns cared for in the NICU experience increased lengths of hospitalization, as well as 
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separation from their maternal/paternal caregivers delaying the process of attachment between 
caregivers and the newborn. 
Neonatal nurses are highly trained in neonatal physiology and technical skills to care for 
the most fragile patients in the NICU. Neonatal nurses must not only assess and manage the 
supportive care of the NAS newborn but also must interact with the addicted mother/caregivers. 
There are emerging findings within the last few years identifying the concept of moral distress 
among neonatal nurses caring for newborns with NAS. Caring for the newborn with NAS may 
be emotionally, physically, and morally taxing on the neonatal nurse who generally during 
his/her education and nursing experience has not been exposed to working with addicted parents 
and families and newborns withdrawing from fetal exposure to drugs. The art and science of 
nursing is beset by caring and nurturing principles that may discourage real life examination of 
what nurses actually feel and do in the patient care settings. Caring for this vulnerable population 
may test the neonatal nurses’ moral integrity and values system leading to moral distress. 
Moral distress if unrecognized and unresolved may have a negative impact on the 
neonatal nurse both personally and professionally. He/she may experience frustration, anger, and 
burn out with unresolved conflicts from moral distress. If we are able to identify and address 
moral distress among neonatal nurses we may have a positive impact on their self-esteem, their 
sense of empowerment and improve quality patient outcomes for the NAS newborn and addicted 
mother/caregivers by providing support systems to protect the neonatal nurse from experiencing 
moral distress’ negative effects, along with the removal of organizational barriers that impede 
education and workflow of the neonatal nurse in the care of the NAS newborn and caregivers.  
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CHAPTER TWO: LITERATURE REVIEW 
The concept of moral distress has early origins within the science of nursing ethics dating 
back to the 1970s and 1980s. These early conceptual frameworks for moral distress promoted 
direct discussions of moral problems that nurses were facing (Jameton, 2013). Moral distress has 
been examined in many clinical settings, especially in critical care units caring for adults and 
neonates. The nature of the NICU is one of advanced technology, highly skilled neonatal nurses, 
and has frequent clinical situations in which moral distress may occur. The body of research thus 
far has explored moral distress in neonatal nurses caring for newborns in palliative care and/or 
end of life care settings. Ethical issues in the NICU are complex and sometimes heart wrenching 
when the neonatal nurse is torn between doing what is in the best interest for the infant, while 
care may be dictated by technological care provisions and parental wishes. These dilemmas lead 
to moral distress for the neonatal nurse. 
Moral distress occurs when a nurse must perform against his/her beliefs because of 
organizational constraints (Corley, 2002). The literature is lacking, however, on the actual 
prevalence and dynamics of moral distress among neonatal nurses when caring for newborns 
with NAS. The emerging and indirect evidence suggests that NICU nurses through the 
examination of their lived experiences may be experiencing moral distress when caring for this 
newborn population (Maguire et al., 2012; Murphy-Oikonen et al., 2010). NAS is a constellation 
of behavioral and physiologic signs experienced by the newborn as a result of cessation of in-
utero exposure to licit and illicit drugs.  
This study explored the possibility for the presence of moral distress in the NICU nurse 
caring for the newborn with NAS. This research study identified the frequency and intensity of 
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moral distress among NICU nurses caring for newborns with NAS. Demographic variables will 
also be considered in relationship to moral distress scores. 
Theoretical and Empirical Literature Examination 
A systematic approach was conducted to utilize a number of databases in the process for 
exploring moral distress in nursing, neonatal nurses and moral distress in the neonatal nurse 
caring for the newborn with NAS. CINAHL, PubMed, MEDLINE, Scopus, and ProQuest 
databases were used in identifying literature from peer reviewed journals from 2004 to 2014 and 
in the English language only. Key terms included but were not limited to neonatal nurses, moral 
distress, and moral distress theories/theorists, neonatal abstinence syndrome, maternal 
addiction, drug dependent parents, substance abuse, and perception of caregivers with the 
addicted patient.   
For the theories of moral distress a search date of 1980 to present captured early research 
published in the mid-1980s. Systematic reviews and the Cochrane database articles were 
reviewed for original research embodied within their reviews for applicability. Exclusion criteria 
included well newborn nurses due to the identified interest of moral distress among neonatal 
nurses by the researcher. 
Review of the Theoretical Literature 
Framework and Scale Development 
 Dr. Mary Corley’s theory of moral distress served as the theoretical framework for the 
study. The predominant focus of Dr. Corley’s research was moral distress among nurses. Dr. 
Corley’s research with nurses led to the development of the MDS. The MDS was first published 
in 1995 and subsequently with continued research has gone through a number of revisions as 
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well as a formulation of a MDS-R pediatric version. Dr. Corley’s work is a progression of the 
earlier published works of Andrew Jameton. 
Moral Distress 
Andrew Jameton, a philosopher, identified the phenomenon of moral distress while 
researching nursing ethics in the mid-1980s. Jameton (1984) perceived moral distress to be a 
painful experience/feelings or the psychological imbalance that occurs when nurses identify a 
morally appropriate action a situation requires but cannot carry out those actions due to barriers 
perceived or actual. As Jameton’s work with moral distress deepened he identified and defined 
the terms of initial and reactive moral distress. With initial distress, the person experiences 
feelings of frustration, anger and anxiety when faced with institutional obstacles and 
interpersonal conflicts regarding values or their value system. Reactive distress occurs when a 
person does not act upon his/her initial distress (Jameton, 1993). Moral distress may affect nurses 
in all health care settings. The professional nurse faces many challenges while providing patient 
care in making the right decisions and taking the right actions. When the nurse is unable to 
adhere to or do what he/she believes is morally correct he/she may experience moral distress. 
Corley’s Theory of Moral Distress 
Dr. Mary Corley’s theory of moral distress guided the study addressing moral distress in 
the neonatal nurse caring for the newborn with NAS. The term moral distress evolved over the 
years from previous research that examined ethical practices in the profession of nursing. Corley 
and Raines in 1993 described how nurses are caring and function as patient advocates. As 
advocates for their patients, nurses may face conflict between patient’s wishes and those of the 
patient’s family, conflict between patient care and medical provider plan of care or constraints 
imposed by the administration or hospital environment. Corley (1995, 2002) theorized that moral 
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distress occurs among nurses when the nurse recognizes what is best for the patient but his/ her 
course of action may conflict with the organization, colleagues, the family structure or society as 
a whole. 
 Dr. Corley examined a sample of critical care nurses administering the MDS to explore 
similarities and differences between critical care and medical floor nurses. During the factor 
analysis nurses working on medical floors reported higher levels of moral distress during 
aggressive care to their patients versus the critical care nurses, F = 5.8, p = .02 (Corley, 1995). 
Also of note, of the 111 nurses in the sample population, approximately 12% had previously 
resigned a position related to their experience of moral distress. Corley’s theory of moral distress 
occurs when the internal environment of nurses (values, psychological responses and/or 
perceived obligations) are incompatible with the needs and philosophies of the external work 
environment (Corley, 2002; Corley & Selig, 1994). 
Corley further theorized that nursing is a moral profession and nurses themselves act as 
moral agents for their patients and families. Common origins of moral distress among nurses 
include:  continued or heroic measures in life support when it is not in the best interest of the 
patient or against a patient’s wishes, lack of communication and understanding between medical 
providers, patient and family conflict regarding end of life care, lack or inappropriate use of 
healthcare resources and/or technologies, inadequate staffing based on patient census/acuity or 
lack of skilled/trained staff to provide safe care, as well as being able to address and relieve a 
patient’s pain effectively (Corley, 2002). Moral distress occurs when the nurse perceives that 
his/her moral integrity is being threatened. If unresolved, moral distress may lead to professional 
burnout and may have a negative impact on patient quality outcomes and escalate health care 
costs. 
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Corley developed a 32-item MDS to measure two aspects of moral distress in nurses:  
frequency and intensity. The MDS was formulated based on Jameton’s theory of reactive distress 
distinguishing it from initial distress. This instrument was developed for use on a sample of 
critical care nurses. Corley identified levels of moral distress intensity (Corley, 1995; Corley et 
al., 2001). Corley et al. (2001) in a subsequent study revealed moderate to moderately high levels 
of moral distress among critical care nurses. 
Impact of Moral Distress 
While Corley appreciates that moral distress may be devastating leading to emotional 
suffering, burn out, resignation from the profession, and may negatively impact patient care she 
also notes that moral distress may have a positive impact. Identification of moral distress 
increases the nurses’ awareness of ethical conflict, empowers the nursing professional to seek 
resolution externally (work environment) or internally through self-reflection leading to seeking 
new knowledge or skills related to patient care and/or outcome. In 2005, Corley et al. examined 
the relationship between moral stress intensity, moral distress frequency, and the ethical work 
environment. This study included a convenience sample of 106 nurses working on medical and 
surgical units. Tools used for the purpose of this descriptive and correlational study included the 
38-item MDS and the Ethical Environment Questionnaire. The researchers wished to examine 
whether the intensity of moral distress was directly related to frequency of moral distress as well 
as if the ethical climate correlated to the frequency and intensity of moral distress. This study 
identified moral distress intensity may be correlated to the degree of moral distress frequency, r 
= .42, p = .01, based on the 38-item MDS and the Ethical Environment Questionnaire identified 
moral distress intensity was significantly impacted by the clinical environment in which the 
nurse practiced in, F = 1.65, p = .038. In this convenience sample of the 106 registered nurses 
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greater than 25% of them revealed previous resignation of their position related to moral distress. 
The researchers believed that rapidly changing technology, conflicting societal and cultural 
values, the pressure to control health care costs and reduced staff ratios of registered nurses all 
contributed to moral quandaries for nurses providing care and may lead to moral distress (Corley 
et al., 2005). 
Dr. Corley through her vast research had identified a need to explore the moral 
component of the nurse’s work environment by developing a more specific understanding of the 
moral responses to conflicts that arise in the work environment that would promote effective 
strategies to address those complex situations. The MDS developed earlier by Dr. Corley was 
used in her study from 2005. Results of importance identified in analysis of the data revealed that 
moral intensity and frequency are concepts that are different but largely experienced by nurses 
working in high acute or critical care settings. An important theme emerged when speaking with 
the nurses, which they (the nurses in the sample setting) continued to experience moral distress 
when the situation was no longer existent. Interestingly enough, the impetus that prompted the 
perception or feelings of moral distress were not removed after the situation no longer existed. 
The presence of moral distress continued long after the situation ceased to exist, leaving the 
nurses with further complexity in their degree of moral distress. 
Studies by Elpern et al. (2005) and Zuzelo (2007) support Corley’s earlier work in which 
the difference between MDS intensity and frequency scores may suggest that while the 
frequency of moral distress is low, it (moral distress) is intensely experienced. 
Hamric and Blackhall (2007) explored the individual perspectives of 196 registered 
nurses and 29 physicians during their care of dying patients in critical care units in two separate 
health care facilities. Overall, the nurses experienced higher frequencies of moral distress related 
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to a negative ethical environment, dissatisfaction within the quality of care administered, and the 
perception of aggressive treatments felt not to be in the best interest of the patient, p = < .001, p 
= < .005, and p = < .001, respectively, than the physician colleagues participating in the study. 
Subsequently, Sauerland, Marotta, and Peinemann (2014) used Dr. Corley’s MDS for 
assessing and addressing moral distress and ethical climate. Sauerland’s results support previous 
studies in which critical care nurses reported higher levels of moral distress in regards to 
intensity and frequency whereas, in the subacute patient care settings those nurses experienced 
moral distress with intensity but less frequently (Sauerland et al., 2014).   
Theoretical Summation 
The body of research of moral distress in nursing has occurred predominantly in critical 
care settings. The degree and frequency of moral distress experienced by the nurse are directly 
influenced by work environments and one’s personal value system. The presence of moral 
distress is a significant problem for the nursing profession as a whole. If moral distress is not 
identified and remedied there may be negative implications for both nurses and patients alike. 
Research has shown that nurses readily admit that empathy is more difficult to achieve in 
situations where their professional ideals are strained and most participants easily described their 
belief that substance abuse during pregnancy and after delivery is a morally deviant behavior 
(Benoit et al., 2014; Shaw, Lederhos, Haberman, Fleming, & Roll, 2016; van Boekel, Brouwers, 
van Weeghel, & Garretsen, 2013). The primary investigator was concerned that moral distress 
may be occurring in the neonatal nurse caring for the newborn with NAS and if unresolved the 
neonatal nurse will experience burnout and avoidance in choosing not to care for this vulnerable 
newborn population which may affect quality of care provided by the neonatal nurse. There can 
be little doubt based on research findings described earlier that many nurses struggle with 
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sincerity to control their personal emotions and convictions while caring for patients in both the 
acute and subacute patient care settings. 
Review of the Empirical Literature 
The diagnosis of NAS among newborns continues to rise whether by maternal history or 
newborn screenings. Caring for the newborn with NAS is both physically and emotionally 
challenging for the neonatal nurse. Major critical themes identified by researchers while 
exploring addiction and their caregivers included nurses’ responses identifying 
counterproductive attitudes when caring for addicted patients or while interacting with family 
members of the addicted patients and feelings of moralistic attitudes regarding addiction to the 
degree that nurses would avoid contact with these patients. In light of the recent surge of NAS 
newborns cared for in the NICU setting, it is important for researchers to understand how 
neonatal nurses feel, as well as react and interact with the newborn with NAS and the substance 
abusing/addicted mother. Recent studies have revealed the existence of strained relationships 
between neonatal nurses and the addicted mother. The study explored the presence of moral 
distress experienced by neonatal nurses when caring for newborns with NAS. 
Neonatal Abstinence Syndrome 
Approximately 15% of women aged 15 to 44 years use drugs at some point during their 
pregnancy (National Institute on Drug Abuse, 2013). Prescription drug abuse occurs in greater 
than 20% of all pregnant women (Substance Abuse and Mental Health Services Administration, 
2013). While pregnancy, generally speaking, is a period in a woman’s life when overall 
substance use is reduced, abuse of illicit and licit drugs continues to occur in women of child 
bearing age. Perinatal substance use and abuse poses both physical and psychological risks to 
both the mother and fetus. 
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The number of newborns with NAS has significantly increased over the last decade. 
Newborns with NAS have higher rates of neonatal complications, prolonged length of stay and 
consume substantial NICU resources. The incidence of NAS has increased from 1.20 to 3.39 per 
1,000 live births here in the United States, almost tripling in the last decade. Maternal use and 
abuse of substances poses a crisis of care for affected fetuses and newborns alike (Hayes & 
Brown, 2012). 
Recently published studies in maternal addiction suggest that in-utero exposure to 
nicotine, SSRIs, benzodiazepines, along with the emergence of designer drugs may influence 
NAS (Wachman, Byun, & Philipp, 2011). The almost epidemic proportions of newborns 
experiencing NAS has lead researchers to focus on the implications and challenges to assist 
neonatal nurses who care for these newborns. Maternal addiction and substance use has been an 
elusive concept not generally identified or addressed during the NICU extensive educational and 
training forums. Neonatal nurses caring for these newborns must possess a unique and diverse 
base of knowledge, clinical skills, and competencies in providing care for this population of 
patients. 
NAS has been described as a constellation of behavioral and physiologic signs caused by 
cessation of exposure to licit and illicit drugs. In the neonate, gestational age affects the severity 
of NAS, with milder symptoms in premature infants born at less than 35 weeks gestation. This is 
thought to be related to the immaturity of the central nervous system, lower fat deposits of the 
drug, and decreased total drug exposure during fetal development (Hudak & Tan, 2012). The 
presentation of NAS is widely variable in timing of onset as well as the severity of exhibited 
symptoms. The mechanisms that underlie the timing and severity of onset are likely to be 
multifactorial and unique to each pregnancy.   
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Characteristic signs of NAS reflect dysfunction of the motor, sensory, and autonomic 
systems. Characteristics commonly seen in the affected newborn include: high pitched or 
inconsolable cry, irritability, sleep and wake disturbances with especially short sleep cycles, 
increased muscle tone/tremors of extremities, feeding difficulties, gastrointestinal disturbances 
(i.e., vomiting and loose/frequent stooling patterns), poor weight gain or failure to thrive, 
sweating, sneezing, mottling of skin, and nasal stuffiness or tachypnea (Jansson & Velez, 2012; 
Hudak & Tan, 2012). In the most severe cases of NAS neonatal seizures may occur. 
 NAS historically has been used to describe neonatal symptoms occurring after in-utero 
exposure to opioids such as heroin, methadone and buprenorphine, and the use/misuse of 
prescription opioid containing medications (hydrocodone and OxyContin). However, other 
substances may produce neurobehavioral disturbances in the newborn consistent with NAS. 
These include alcohol, benzodiazepines, nicotine, marijuana, and antidepressants/antipsychotics. 
Exposures such as cocaine, nicotine, SSRIs, and polydrug use can potentiate the newborn’s 
expression of NAS. 
Opioid-related NAS may mimic other physiological conditions seen in the neonate. Of 
utmost importance is the review of maternal history, maternal use of any/all medications, and 
compliance for urine drug screening for both mother and newborn if self-reported use or high-
risk behaviors have been identified. Clinical signs of the newborn should not be solely attributed 
to drug withdrawal without careful assessment to exclude other etiology. Once a newborn is 
identified to be at risk for NAS a thorough assessment and implementation of non-
pharmacologic interventions should be considered. The assessment for need to introduce a 
pharmacologic agent to alleviate the severity of a newborn’s symptomatology will be discussed 
later in this chapter. Although studies are limited in nature and sample size, the evidence 
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suggests that the use of nonpharmacologic therapies may benefit the newborn with NAS by 
decreasing clinical symptoms. 
Management of NAS 
The goals of nonpharmacologic interventions are to promote supportive parenting 
behaviors and decrease external stimuli that tend to exacerbate a newborn’s withdrawal 
symptoms (Maguire, 2014). Velez and Jansson (2008) demonstrated that nonpharmacologic 
interventions lead to a comprehensive approach of care to structure and nurture maternal–infant 
interactions and attachment as well as provide a care environment that supports 
neurodevelopmental and physiologic stability for the newborn.   
 Some common therapies that may be utilized by all levels of caregivers include: low 
lighting and quiet care environments, clustering of care, swaddling and use of pacifier with 
newborn, slow rhythmic rocking, kangaroo care (skin-to-skin contact between mother and her 
newborn), and encouragement to breast feed infant if mother is HIV negative and has been 
compliant in a drug therapy program. Sakar and Donn (2006) published results of a national 
survey for the management of NAS in NICU’s across the country. Of note was variability from 
practices or within practices where some clinician groups used published abstinence scoring 
tools while others performed under inconsistent assessment and intervention strategies. 
As the incidence of NAS and its impact on health care and newborn outcomes increases 
and becomes more apparent it is critical for neonatal clinicians and care teams to embrace a 
common, objective, and validated scoring tool to guide diagnosis and treatment modalities for 
NAS. The American Academy of Pediatrics recommends formulation of a standard guideline for 
caring for all newborns with NAS within health care settings caring for mothers and newborns. 
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The American Academy of Pediatrics also recommends the use of a standard scoring tool to 
identify and “quantify” severity of withdrawal symptoms demonstrated by the newborn.   
Two of the most commonly used tools for scoring a newborn were formulated after 
research in the 1970s observing newborns with withdrawal symptoms. Those tools are the 
FNAST scoring tool and the Neonatal Drug Withdrawal Scoring System (Finnegan et al., 1975; 
Lipsitz, 1975).    
 Dr. Loretta Finnegan and colleagues began to observe an increase in their nurseries of 
newborns born to addicted mothers who exhibited a unique pattern of symptoms not recognized 
in the newborn of non-addicted mothers. Finnegan and colleagues along with the departments of 
Obstetrics, Neonatology and Psychiatry at Philadelphia General Hospital embarked on a study of 
maternal addiction with narcotics and what they called “passive” addiction in the neonate 
(Finnegan et al., 1975). Review of the literature and close clinical observation of over 200 
newborns lead to the development of the most comprehensive tool used to measure NAS 
symptoms in the newborn (Finnegan et al., 1975). Methods for measuring narcotic abstinence 
had been described in animal models in 1970 and previously in the human adult population in 
1942. Until the development of the Finnegan scoring tool objective scoring methods for use in 
the newborn was not available to researchers or clinicians.  
The development of the Finnegan scoring tool was a precise method for scoring clinical 
manifestations for those newborns exposed to in-utero narcotic use by their addicted mothers. 
Scoring of these newborns would guide therapeutic decision making and was an important 
contribution to the science of neonatal medicine. This tool would later be used as an investigative 
tool to compare various pharmacological agents used in the treatment of NAS. The tool allowed 
for assessment before, during and after therapies to validate the presence of an increase of scores, 
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which would reflect treatment failure or where a decrease in scores directed researchers to 
explore those therapies thought to reflect a therapeutic response. 
Pharmacologic Management of NAS 
 Generally speaking, serial scores of greater than 8 warrants the addition of a 
pharmacologic agent to already established comprehensive assessment and care. Scoring of the 
newborn guides the clinician in pharmacological management once initiated to establish 
parameters for increasing, decreasing, or discontinuing the agent in use. The goals of 
pharmacological management is to stabilize and minimize symptoms to ensure newborns with 
NAS can eat well and gain weight, establish fairly normal sleep-wake cycles, promote 
socialization with caregivers with successful attachment to their maternal care giver and prevent 
untoward outcomes, for example, neonatal seizures (Hudak & Tan, 2012). 
With the steady increase of substance use and abuse among child bearing women 
resulting in higher incidence of NAS newborns being cared for in the NICU setting neonatal 
clinicians must embrace guidelines to manage the care of this at-risk population while preserving 
the professional well-being of the NICU nurse caring for the newborn with NAS. 
Moral Distress of Neonatal Nurses 
 While the research regarding moral distress in the neonatal nurse is not bountiful 
published works are meaningful to the profession. Corley and colleagues over the years 
researched the level of moral distress in adult critical care and adult palliative care settings.  
Those same settings are similar to work environments for the neonatal nurse. Corley’s theory of 
moral distress proposes a direct relationship between moral distress, nurse satisfaction, and 
retention within the profession. The nature of the NICU is to preserve life, possess critical 
problem-solving skills, and clinical expertise in using lifesaving equipment as well as provide 
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education and emotional support to parents and families. The degree and frequency of moral 
distress among neonatal nurses is variable and dependent on the clinical/ethical scenario, 
personal beliefs and threat to the moral integrity of the neonatal nurse (Cavaliere et al., 2010; 
Janvier et al., 2007; Sauerland et al., 2014; Zuzelo, 2007).   
Cavaliere et al. (2010) performed a descriptive/correlational study to examine moral 
distress among neonatal nurses in the NICU setting. The convenience sample of neonatal nurses 
was from a large health care system in the northeast region of the United States. A data sheet to 
capture demographic variables was utilized as well as Corley’s MDS Neonatal-Pediatric version. 
Ninety-four of 196 eligible neonatal nurses participated yielding a 48% response rate. Responses 
of the sample resonated results of previous studies regarding moral distress situations by use of a 
quantitative approach. The greatest degree of moral distress occurs within these recurrent 
themes: futile or aggressive care is thought to be without perceived benefits, pain and suffering 
not alleviated by care or as a direct result of care, inadequate staffing and working within an 
interprofessional group model where some colleagues may not be competent to perform 
specialized care of newborns required in the NICU. 
Caring for the newborn with NAS and interacting with the addicted mother may arouse 
moral distress and may be both physically and emotionally challenging for the neonatal nurse. 
Newborns with NAS may require prolonged care in the NICU.   
 Newborns with NAS that require medical management in the NICU secondary to their 
withdrawal is reaching crisis levels in neonatal care centers throughout the United States. The 
care of these newborns is challenging and may be both emotionally and physically draining to 
the neonatal nurse. It is important for researchers to understand how neonatal nurses feel, as well 
as react and interact with the newborn with NAS and parents. In a study of cocaine-exposed 
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infants and their mothers the attitudes of the nursing staff were found to be generally negative 
and this negativity impacted adversely on quality nursing care (Raeside, 2003). Generally 
speaking the researcher posits that these nurses may have been experiencing moral distress 
which in the early 1970s and 1980s possessed origins in nursing ethics but had not been studied 
in clinical settings or a variety of patient populations (Jameton, 2013).  
 Recent studies have indicated that there are strained relationships between the neonatal 
nurse and the addicted mother/parents (Maguire et al., 2012; Murphy-Oikonen et al., 2010). 
Maguire et al.’s (2012) study applied a phenomenological method to identify neonatal nurses’ 
lived experiences of ethical and moral issues when caring for newborns with NAS. Sixteen 
nurses were interviewed over a 2-month period involving 1-hour long interviews. The sample 
size was small (N =16), but overall the emerging themes are critical; neonatal nurses expressed 
genuine caring towards these newborns and their desire to provide quality care to the newborns 
during their withdrawal but expressed frustration and distress (possibly moral) when they were 
not able to console or comfort the newborn. Based on participant responses it was evident that 
ethical and moral distress occurred in this neonatal nurse sample while caring for these newborns 
and during interactions with the addicted mother or parents. Participant neonatal nurses were 
concerned with the mother’s ability to cope and care for their irritable newborn after discharge as 
well as acknowledged feelings of negatively judging the addicted mother; neonatal nurses’ 
demonstrated anger towards the mother for causing their infant’s withdrawal. Fraser et al. (2007) 
published their findings from their semi-structured, open-ended interviews among eight neonatal 
nurses supporting the recurrent theme that distress and moral attitudes may have a negative 
impact for both the neonatal nurse and her ability to promote family centered care to this 
vulnerable mother/infant dyad. 
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 An additional theme identified in these studies that may lead to further progression of 
moral distress is the presence of role confusion as a neonatal nurse. Participants verbalized their 
beliefs that newborns experiencing NAS did not need specialized care in the NICU and that the 
environment is too busy and over stimulating for those newborns. The study participants 
believed newborns with NAS were not “sick” enough to warrant critical care and the expertise of 
the nurses’ clinical skills (Maguire et al., 2012; Murphy-Oikonen et al., 2010).   
In the study conducted by Murphy-Oikonen et al. (2010), “stress, frustration and 
burnout” was an additional identified theme, which are all directly related to occur due to the 
perceived or unperceived presence of moral distress. The researchers used a qualitative design 
with open-ended questions via a computer-assisted interview process. The sample size included 
14 neonatal nurses employed in the NICU in a regional hospital. An immersion process was the 
approach method for data analysis. Reflectively, while all of these studies had small sample sizes 
each of them identified similar and critical themes for neonatal nurses caring for newborns with 
NAS, which include but are not limited to: role confusion among caregivers, negative attitudes 
towards addiction, and the presence of moral distress among neonatal nurses caring for the NAS 
newborn. 
In a 2014 study by Cleveland and Bonugli, mothers of infants in the NICU with NAS 
perceived non-supportive neonatal nurses’ attitudes and beliefs as well as a lack of knowledge 
related to addiction. The sample size was a convenience sample of 15 substance addicted 
mothers from a community-based, outpatient, addiction treatment facility in a large urban area. 
The research method included semi-structured, individual interviews and analysis of data used 
qualitative content analysis. Data were analyzed independently and discussed until themes 
emerged by consensus. Although the sample size was small recurring themes for these mothers 
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included feeling judged, not being seen as a human being because of their addiction and not 
being acknowledged as the mother who wants to share in caring for her newborn. Interestingly, 
another theme that surfaced was the perception of the mothers that there was variability from 
nurse to nurse in how their newborns were scored using the NAS tool. The mothers were aware 
that the scoring of their newborn dictated the readiness for discharge. Some mothers felt that if 
they had a good rapport with the neonatal nurse the infant had lower scores and when they 
perceived the negativity of the nurse their infant had higher scores. Another mother expressed 
concern during her interview that a nurse who had never cared for her daughter before had 
scored her too high. The mothers shared their thoughts on the use of the tools to score their 
newborn describing the use of these instruments as highly subjective as the nurses scored the 
newborns with great variability (Cleveland & Gill, 2013).   
Although one of the limitations of this study was the small sample size a great deal may 
be gained from the maternal narratives. The narratives and recollections of these mothers 
occurred in varying time lengths after hospital discharge. The length of time that passed between 
the newborn’s discharge and the mother’s interview session ranged from 2 weeks to 2 months; 
therefore, a relatively short time had passed and mothers were able to vividly recall their 
feelings, perceptions, and interactions with the neonatal nurses engaged in their newborn’s care. 
Variation in scoring among care givers has been demonstrated in previous works in the literature 
regarding NAS scoring tools (Crocetti, Amin, & Jansson, 2007; Hudak & Tan 2012; Sakar & 
Donn, 2006). However, in these studies variations were attributed to subjectivity in use of tool, 
complexity of the tool, lack of knowledge and formal training in use of the tools, as well as an 
ongoing program to ensure competency in tool use. 
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The research regarding moral distress in the neonatal nurse has been limited and mainly 
explored in regards to end of life care. Given the aforementioned studies, moral distress appears 
to be evident among neonatal nurses caring for the newborn with NAS and possibly plays a role 
in how the nurse interacts with the addicted mother/parents. Yet, whether moral distress exists 
and in what degree and/or frequency is unknown. NAS is a complex diagnosis, with newborns, 
families and neonatal nurses all having individual needs that must be carefully and thoroughly 
recognized to assist in physical and mental well-being of all. Establishment of an evidenced 
based approach that acknowledges the potential interact of moral distress is important to both 
newborns with NAS and neonatal care givers that will improve outcomes. This research explored 
the presence of moral distress among neonatal nurses caring for newborns with NAS.    
Empiric Summation 
 The diagnosis of NAS among newborns continues to rise, reaching epidemic proportions 
as reflected by researchers. In light of the recent surge of NAS newborns cared for the in the 
NICU setting it is imperative for researchers to explore and understand how neonatal nurses feel, 
as well as react and interact with the NAS newborn and the substance abusing or addicted 
mother. Caring for the newborn with NAS is both physically and emotionally challenging for the 
neonatal nurse. Recent studies have revealed the existence of strained relationships between the 
neonatal nurse and the maternal caregiver which could be related to moral distress experiences 
and perceptions in the neonatal nurse caring for the newborn who is withdrawing due to 
substance misuse/abuse of the mother. 
Summary 
Moral distress occurs in several health care settings and may directly impact the 
registered nurse and patients under his/her care. The presence of moral distress may cause burn 
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out among nurses and precipitate a nurse leaving the profession completely. Moral distress 
experienced by caregivers if unresolved also impacts the quality of patient care in a negative 
manner. Care of the newborn with NAS may lead to moral distress among neonatal nurses. Dr. 
Corley’s theory of moral distress guided this research to assess for the presence and degree of 
moral distress. The FNAST is commonly used in most NICUs across the United States. This tool 
provides a standardized language and assessment parameter to quantify a newborn’s withdrawal 
symptoms. The tool is an accepted method to provide direction for the pharmacologic and 
comprehensive management of a newborn with NAS.  
The primary investigator postulated that moral distress is experienced by neonatal nurses 
during the care of newborns with NAS. The use of Corley’s MDS-R pediatric version identified 
the frequency and intensity of a neonatal nurses’ moral distress. Moral distress affects the quality 
of patient care, outcomes and the well-being of the professional nurse.   
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CHAPTER 3: METHODS 
The NICU environment has the potential for frequent clinical situations in which moral 
distress may be experienced by the neonatal nurse. The body of research thus far has explored 
moral distress among neonatal nurses caring for newborns requiring palliative or end of life care. 
Ethical issues in the NICU are often complex. Neonatal nurses may be torn between performing 
in the best interest of the patient while care may be dictated by technological care provisions and 
parental wishes. These dilemmas lead to moral distress for the neonatal nurse. Moral distress 
occurs when a nurse must perform against personal beliefs because of organizational constraints 
(Corley, 2002). 
Emerging data has identified the presence of distress and frustration among neonatal 
nurses caring for newborns with NAS. Neonatal nurses caring for newborns with NAS may 
experience moral distress to varying degrees (Maguire et al., 2012; Murphy-Oikonen et al., 
2010). Moral distress may have a negative impact on patient care, and the well-being of nurses 
due to unresolved ethical conflicts (Cavinder, 2014; Cavaliere et al., 2010; Janvier et al., 2007). 
The purpose of this study was to explore the presence of moral distress among neonatal 
nurses caring for newborns with. This chapter describes the study design, sampling plan, 
instrument selection, data collection, and treatment of data to address the research question 
identified. 
Study Design 
The design was a pilot study using descriptive methodology to address the following 
research question: Do neonatal nurses experience moral distress when caring for newborns with 
NAS whose mothers used illicit substances during pregnancy? 
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The study was non-experimental and descriptive. The principal investigator did not 
introduce an intervention. Data collected identified the presence of moral distress among 
neonatal nurses caring for newborns with NAS. Therefore, the primary investigator recorded 
actual scores from the participant sample in the data collection process and reviewed all 
responses recorded by participants from the moral distress scale. The MDS-R Pediatric version 
measured frequency and intensity of moral distress in neonatal nurses caring for newborns with 
NAS. The descriptive design allowed the primary investigator to establish the exposure of moral 
distress with regards to frequency and intensity based on the neonatal nurses’ responses in the 
sample population when caring for newborns with NAS.   
Sample and Setting 
The available population included approximately 40 to 45 registered nurses working in a 
Level III NICU in the Northeast region of the United States was identified. This was a 
convenience sample due to the establishment of only one NICU within this health care system 
for recruitment of study participation. Inclusion criteria for participation in the study included 
any neonatal nurse employed part-time or full-time in the NICU because these nurses would 
regularly care for newborns with NAS. No exclusion criterion for study participants was 
established. Demographic data collection served to describe the sample of volunteer participants, 
and assisted in establishing or refuting homogeneity among the neonatal nurses. The setting is a 
Level III NICU from a 386-bed community medical center in the Northeast region of the United 
States. 
There is limited guidance with respect to sample sizes for pilot studies. Some research 
experts recommend 10 participants or 10% of the final study size, while others note that sample 
size be guided by the constraints of the chosen population (Hertzog, 2008). Generally speaking, 
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accepted sample sizes for pilot studies depending on purpose of the study range between 10 and 
40 participants. There are approximately 40 to 45 neonatal nurses at any given time employed 
within the inclusion group in the chosen setting. Due to the scant evidence within published 
studies on moral distress among NICU nurses caring for newborns with NAS it may be difficult 
to determine an effect size for the identified pilot study. 
Sample recruitment for the neonatal nurses was multilayered. An informational poster 
(see Appendix B) in the staff lounge described the alarming rates of newborns born with NAS 
and the importance of the study. Group discussions regarding the research study occurred at 
leadership and staff meetings, as well as during pre-rounding for patient care rounds, which are 
held daily. Pre-rounding was incorporated into patient care rounds for both day and night shift 
neonatal nurses to reach as many potential participants as possible. Study results were 
disseminated to the all the NICU staff members using the same strategies as in recruitment. 
Protection of Human Subjects 
Prior to the participation of neonatal nurses and the initiation of data collection approval 
was obtained from the health care facility’s Institutional Review Board. Participants for the study 
were neonatal nurses from the chosen health care facility. The data collected and obtained were 
used solely for research purposes, including the completion of demographic questionnaire and 
self-reported scores by the neonatal nurses in completing the MDS. 
Potential risks associated with participation in this study were unlikely and of low risk. 
Participation in completion of the MDS and demographic questionnaire cannot result in physical 
harm. Participants were asked to provide information regarding their self-reported scores from 
their completion of the MDS, and completion of the questionnaire containing demographic 
information. These questions had a small likelihood of psychological risk to the participants. 
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Prior to dissemination of the study, particular attention was placed on assuring ethical 
treatment of the human subjects. The right of the human subjects for self-determination was 
guaranteed through the use of voluntary and anonymous participation. Volunteer subjects had the 
right to freely choose to participate or to decline participation without penalty or loss. The only 
potential infringement of the right to self-determination that may have been construed during the 
study was the possible perception of coercion on the behalf of potential subjects. The principal 
investigator was a colleague of the volunteer subjects and possessed a position of authority as an 
advanced practice registered nurse in relation to that of the subjects. However, the investigator’s 
collegial role did not include supervisory leadership duties for the subjects, nor did her role 
involve any form of performance or employment appraisals. The principal investigator was 
employed by, and reported to a private practice physician group, while the volunteer participants 
were employed by the hospital. 
Distribution of the MDS and the demographic questionnaire was placed in all eligible 
participants’ mailboxes. An introductory letter (see Appendix C) described for the potential 
participants that the study was completely voluntary and anonymous, identified that participation 
was of low risk and any question may be deferred if the question produced a psychological 
disturbance to the participant. The potential for perception of participant coercion was also 
acknowledged with a statement within the body of the letter noting that the lack of participation 
in no way affected their employment or evaluative process. Participants completing and 
returning the demographic and moral distress scale signified their desire to participate in the 
research study voluntarily and anonymously. Participants understood the low risks involved in 
participation of the study, and that the opportunity to defer to answer any question that produced 
a psychological disturbance was an option during completion of the instrument. Participants 
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were assured that all information shared with the principal investigator was kept strictly 
confidential. Volunteer participants were able to access the introductory letter with study packets 
directly from their mailboxes. No identifiers were used on the packets because the study was 
anonymous. Only the principal investigator had access to review the de-identified data. 
Demographic questionnaires and MDS were stored in separate locked file to protect the 
confidentiality of participants, as well as the confidentiality of participant responses in the 
secured files in the locked office of the principal investigator.  
The participant’s right to autonomy, anonymity, and confidentiality was protected and 
maintained through the secure storage of completed study instruments. Access to the completed 
study instruments was only accessible to the principal investigator within the locked file in the 
key secured investigator’s office, and with additional protection through computer password 
recognition. Only the principal investigator had knowledge regarding the protected password 
entry mechanism. 
The right to fair treatment was ensured by the explanation of potential benefits and risks 
to the subjects within the body of the introductory letter. The potential benefit of participation 
assisted the principal investigator to establish the degree and frequency of moral distress 
occurring in the neonatal nurse caring for newborns with NAS in current practice. The potential 
risk to participant subjects was minimal, and would be limited to the emotional distress 
associated with self-reflection in responding to items within the subject matter. 
Data Instruments 
The formal instrument for data collection utilized within this study was the MDS-R 
Pediatric version (see Appendix D). A demographic questionnaire (see Appendix E) was 
constructed by the principal investigator to assess demographic information such as, age, 
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education levels, and neonatal nurses’ perceptions regarding moral influence as it pertains to the 
care of newborns with NAS with the use of a few forced choice questions. Gender identification 
was eliminated due to the presence of one male registered nurse employed by the setting 
hospital. The purpose of obtaining and analyzing demographic data assisted the principal 
investigator to establish or refute homogeneity among the participant group of neonatal nurses 
for generalization of the research findings, and provided descriptive characteristics of the study 
participants. 
Demographic Questionnaire 
The demographic questionnaire addressed and identified variables of the sample group of 
volunteer participants. Descriptive analysis defined the characteristics of the sample participants. 
The nominal (categorical) level of measurement allowed for grouping of participants into broad 
categories by the principal investigator. Questions numbered one through seven identified 
discrete data, which included, but was not limited to, age, education levels, and number of years 
of employment. This data denoted nominal levels of measurement. The questions numbered 8 
through 12 regarding moral influence denoted ordinal levels of measurement. Question 13 was 
an open-ended question to validate the participant’s response to Question 12. The principal 
investigator postulated that participant responses to Questions 8 through 13 preliminarily 
identified neonatal nurses at risk for experiencing moral distress when caring for newborns with 
NAS. 
Moral Distress Scale 
The original work to measure moral distress included assessment through a one-time 
visual analog scale. Over 80% of the nurse participants reported medium to high levels of moral 
distress (Corley & Selig, 1994). These discoveries regarding the high degree of moral distress 
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lead Corley et al. (2001) to identify the causes and severity of moral distress. Their research was 
based on three assumptions: (a) nurses bring their values and value systems into work with them, 
(b) nurses can identify ethical dilemmas in their work environment, and (c) nurses can identify 
the extent to which their values and ethics may cause moral distress. 
The MDS was developed (Corley et al., 2001). The original MDS measured the 
frequency and intensity of moral distress within a 32-item 7-point Likert format; a higher score 
reflected higher level of moral distress. During the development of the instrument early content 
validity was established through content analysis of interviews from nurses in the United States. 
The second phase of content validity was achieved through review of two experts of moral 
distress (Dr. Wilkinson and Dr. Jameton) and subsequently a panel of doctoral prepared nurses 
with expertise in nursing ethics leading to the final creation of a 38-item scale (Corley et al, 
2001). The MDS instrument has demonstrated adequate reliability, Cronbach’s α from .82 to .98 
(Corley et al., 2005).  
In 2012, Hamric et al. revised the MDS scale to create a revised and shortened version of 
the original 38-item scale. The revised and abbreviated scale now identified as the MDS-R 
contains 21 items and responses were modified from a 0-to-6 Likert scale to a 0-to-4 Likert 
scale. The scale for frequency ranges from 0 (never) to 4 (very frequently) and for intensity from 
0 (none) to 4 (great extent). Frequency and intensity scores for each item may be scored and 
examined separately; in addition the MDS-R possesses the possibility for computing a composite 
score, which is useful in multivariate analyses (Hamric et al., 2012). Composite scores of the 
frequency and level of distress were also an addition in the MDS-R; calculations for scores are 
established through multiplication of the two scores for each item and then summation of scores 
across the items (Hamric et al., 2012).   
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In the MDS-R, each item has the ability to have a score range from 0 to16 and a 
summative score range of 0 to 336. Cronbach α for the MDS-R is .89. The revised scales 
included six parallel versions to enhance clarity and broaden applicability beyond critical care to 
all inpatient settings, and to address moral distress among other providers within the health care 
professional team (Hamric et al., 2012). The MDS-R Pediatric version was used to identify 
moral distress in neonatal nurses caring for newborns with NAS. The use of the Likert scale 
responses allowed for numeric categories ordered from a low score to a high score. A frequency 
distribution table identified the measure dispersion of scores of the neonatal nurse sampling. A 
histogram demonstrated the frequency and intensity scores for each of the sample participants 
with regards to the clinical scenarios reflective of caring for newborns with NAS. Composite 
scores (frequency x intensity) are recommended by the developers of the instrument for use with 
multivariate analysis (Hamric et al., 2012). Written permission was granted by Dr. Hamric for 
use of the instrument as well as minor revisions to content through personal correspondence 
February 2015 (see Appendix F).  
Procedure for Data Collection 
Institutional Review Board approval through the chosen health care facility was obtained 
prior to any recruitment of volunteer subjects. Eligible volunteer subjects were neonatal nurses 
employed at least part-time in a Level III NICU in the Northeast region of the United States. 
Recruitment of the subject group occurred through the informational poster presentation, 
discussion of purpose of study at staff meetings and during pre-rounding on the day and night 
shifts consecutively for a 2-week period. 
  The principal investigator provided instructions for completing and submission of both 
the demographic data questionnaire and the MDS packet within the informational letter. Study 
  
45 
packets included a cover letter describing the purpose of the study, the demographic 
questionnaire and the MDS. Each packet was placed in every potential volunteer neonatal 
nurse’s mailbox within the NICU along with a small box of gourmet chocolate to thank them in 
advance for their interest and participation in the study. The principal investigator requested the 
return of completed forms no later than 72 hours from procurement or the next scheduled shift 
for the participant; whichever came first. The participants were provided with instructions to 
return the completed questionnaire and scale to the NICU locked opinion box, which is used for 
any confidential comments or suggestions when staff wishes to remain anonymous. This box is 
secured to the main wall in the common staff area. During the research time period a new lock 
was placed on the box by the principal investigator to secure information. At the end of the 
research study the investigator’s lock was removed and nursing leadership regained and was 
responsible for securement of the opinion box. There was no cost involved for duplication of 
documents by the principal investigator. 
Treatment of Data 
SPSS Version 24.0 was utilized for data entry and analysis. Completed packets from 
subjects were opened individually and demographic questionnaire was reviewed for 
completeness and results recorded into the password protected computer. The MDS scores were 
handled in the same manner. Scoring included intensity and frequency values determined by 
participant responses. All collected forms and computer files were kept in separate locked 
cabinet in the principal investigator’s office.   
SPSS was downloaded to a portable laptop computer, which remained secured in the 
locked office and was password sensitive with high complexity to safeguard data. This identified 
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procedure occurred with every participant’s data review, collection, formulation of values, and 
that same data were recorded into SPSS Version 24.0. 
Data recorded manually and electronically was reviewed for accuracy by comparing the 
data responses to the demographic questionnaires and self-reports by the neonatal nurse within 
the MDS-R instrument. If variables were missing data or data appeared erroneous, again a 
review of the original packet data. Sample characteristic recovery was performed through 
descriptive statistics to display the study population. Measurable outcomes explored in the study 
included the level of moral distress experienced by neonatal nurses caring for newborns with 
NAS. The MDS-R identified and measured the level of moral distress for each participant. The 
frequency and intensity of moral distress experienced by the neonatal nurse was analyzed 
through individual scoring within the moral distress instrument.   
Analysis of Data 
The research question addressed in the study was as follows: Do neonatal nurses 
experience moral distress when caring for newborns with NAS whose mothers used illicit 
substances during pregnancy? 
The research question as stated above was answered using nurses’ self-reflected 
responses to items on the MDS-R Pediatric version. Scores identified the absence or presence of 
moral distress, in which the higher the score the higher the level of moral distress. Descriptive 
statistics including a frequency distribution reflected the existence (intensity) of moral distress 
and its frequency among neonatal nurse. The graphing of the moral distress intensity and 
frequency scores was demonstrated through the use of a histogram for the clinical scenarios. 
The study design was a non-experimental pilot study with descriptive design. Descriptive 
studies are those that seek to describe phenomena, not necessarily formulating a statement in 
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regards to association or causation. Descriptive statistics were utilized to describe the 
characteristics of the sample population. The purpose of this study was to identify the presence 
of moral distress among neonatal nurses caring for newborns with NAS. This pilot study did not 
seek to describe if any causal relationships existed. Descriptive measures may reveal a great deal 
of information regarding any variable of interest, whether the data analyzed originates for 
clinical, administrative, and educational or research purposes. 
The MDS-R instrument measured responses based on a Likert scale. Likert scales are 
often used to represent ordinal data. Ordinal measures have categories and magnitude, but they 
do not have equal intervals.  A measure of central tendency; the mean identified the degree of 
moral distress with the greatest frequency, highest intensity and overall levels of moral distress 
respectively for the sample group participants reflecting responses to each of the clinical 
scenarios. 
Descriptive statistics including the frequency distributions histogram was used to present 
the portion of the sample participants’ levels of moral distress: no moral distress, mild moral 
distress, moderate moral distress, and severe moral distress. A frequency histogram is a bar 
graph representing the number of participants for each score for the ordinal variable of moral 
distress. The frequency identified the incidence of moral distress among neonatal nurse caring 
for newborns with NAS in the sample population. 
Formative evaluation for the study included input from major and associate advisors, 
experts on the identified subject matter, consistent mechanism for recruitment and protection of 
the human subjects, data collection/entry, and independent statistical evaluation.   
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Summative evaluation disclosed the sample size, as well as the presence or lack of 
homogeneity of the sample subjects. Final conclusions and study results were shared with the 
NICU staff at the identified health care facility serving as the study setting. 
Summary 
The purpose of this study was to explore for the presence of moral distress in neonatal 
nurses caring for newborns with NAS. The use of a descriptive design allowed the principal 
investigator to be able to describe the phenomena of moral distress within care of newborns with 
NAS. The principal investigator did not introduce an intervention. A descriptive design assists a 
researcher to examine and describe characteristics or groupings of a single sample in order to 
generalize their findings to a single population. This design is also helpful to generate new 
knowledge when little or no known knowledge is available through published bodies of research. 
The frequency and level of a nurses’ moral distress was determined from the self-reported scores 
from the MDS-R Pediatric version. The presence of moral distress among neonatal nurses may 
negatively affect the care of newborns with NAS, and jeopardize the mental well-being of the 
neonatal nurse. 
Research thus far, while limited, has identified that indeed neonatal nurses may 
experience moral distress when caring for newborns with NAS. These findings highlight the 
importance for recognition to preserve the self-integrity of the neonatal nurse, as well as insure 
safe and appropriate care for the newborn exhibiting signs of substance withdrawal while 
supporting attachment between the maternal–infant dyad. 
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CHAPTER 4: STUDY RESULTS 
 The purpose of this study was to explore the presence of moral distress among neonatal 
nurses caring for newborns with NAS whose mothers used illicit substances during pregnancy. 
Chapter 4 identifies the research question, characteristics of the sample participants in the pilot 
study, and methods for data collection. The findings within this study apply to the specific 
population of neonatal nurses from a Level III NICU in a health care facility in the Northeast 
region of the United States. A descriptive, non-experimental design guided the study. The 
principal investigator’s primary intention was to identify the presence of moral distress among 
the group of sample participants. No intervention inquiry was considered during this pilot study.   
A total of 44 neonatal nurse participants were identified for study eligibility. A packet 
containing an informational letter, demographic questionnaire, and the MDS-R instrument were 
placed in the mailbox for each potential volunteer participant. The data were collected from 
April 1, 2017 through to April 17, 2017. The total number of volunteer study participants was 27 
out of 44, yielding a 61% response rate. 
The principal investigator employed the use of the MDS-R Pediatric version instrument 
to measure the frequency, intensity, and overall level of moral distress (composite score) within 
the sample participants. The following clinical scenario questions were added to the instrument 
for measurement of frequency, intensity, and level of moral distress to specifically address 
reflective values of neonatal nurses caring for newborns with NAS: 
Question 22: Caring for newborns with NAS is not professionally satisfying. 
Question 23: Caring for newborns with NAS is time consuming and takes away time that 
should be afforded to critically ill preterm infants. 
Question 24: My clinical skills are wasted on caring for newborns with NAS. 
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Question 25: Interacting with substance misusing mothers/parents is often negative in 
nature due to mistrust and addictive behaviors demonstrated by caregivers. 
These additional clinical scenario question may identify additional root causes promoting 
moral distress according to the research published thus far on NAS in regards to professional 
caregiver and parent interactions (Fonti, Davis, & Ferguson, 2016; Maguire et al., 2012; 
Murphy-Oikonen et al., 2010; Raeside, 2003).  
Characteristics of Study Participants 
The study participants were a purposive sample of neonatal nurses from a Level III NICU 
in the Northeast region of the United States. Demographic data were obtained through the 
completion of the demographic questionnaire. Table 2 describes the demographic characteristics 
of the study participants reflecting age, years employed as a registered nurse, years employed as 
a neonatal nurse, educational levels, years in caring for newborns with NAS, influence of moral 
beliefs when providing care, and summation of the open-ended questions regarding NAS. 
Gender was not a requested identifier to maintain the anonymity of the one male nurse employed 
within the NICU.  
Additionally, two questions regarding leaving or consideration of leaving his/her nursing 
staff position secondary to the presence of moral distress were asked exclusive of the 25-item 
instrument. These two questions were part of the instrument Dr. Corley and Dr. Hamric 
developed. Research by Dr. Corley demonstrated that nurses left a clinical nursing position 
primarily due to moral distress (Corley, 1995). Bodies of research have demonstrated that nurses 
with higher levels of moral distress significantly consider leaving their positions more 
frequently, contributing to the shortage of professional nursing caregivers (Cavaliere et al., 2010; 
Ganz & Berkovitz, 2012).   
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The responses for this sample of participants are represented in Table 1. Fifteen of the 
participants (18%) stated that they have never considered leaving a position secondary to moral 
distress, eight (3%) stated yes, they had considered leaving but did not, and four of the 
participants (6%) indicated they left a clinical position secondary to moral distress. Three of the 
27 participants (9%) identified that they were considering leaving their current clinical position 
in the NICU. 
Table 1 
Considered Leaving Position 
Item Frequency 
Have you ever left or considered quitting a clinical position because 
of your moral distress with the way patient care was handled at your 
institution? 
 
No, I’ve never considered quitting  15 
Yes, I considered quitting but did not leave 8 
Yes, I left a position 
 
4 
Are you considering leaving position now?  
Yes 3 
No 24 
  
The average age among participants was 40 to 49 years of age, 48.1% (n = 13). An 
associate nursing degree was held by 37% of participants (n = 10), a baccalaureate degree was 
held by 55.6% of participants (n = 15), and 7.4% of participants held a graduate level degree (n = 
2). None of the sample participants held a diploma or doctorate level degree. The number of 
years employed as a registered nurse was greater than 10 years with 88.9% of participants (n = 
24); in regards to years working in a NICU, the majority of participants at 74% (n = 20) had 
worked in a NICU for greater than 10 years. A majority of these neonatal nurses at 81.4% (n =  
22) have cared for newborns with NAS for greater than 5 years; whereas, 18.5% (n = 5) of nurses 
have cared for these newborns less than or equal to 5 years. 
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Table 2 
Sample Characteristics 
Sample Characteristics           n (%)                                   
Age  
20–29 1 (3.7) 
30–39 5 (18.5) 
40–49 13 (48.1) 
50 years or older 8 (29.6) 
Highest level education  
Diploma 0 (0) 
Associate 10 (37.0) 
Baccalaureate 15 (55.6) 
Graduate 2 (7.4) 
Doctoral 0 (0) 
Number of years RN  
Less than 2 years 1 (3.7) 
3–5 years 0 (0) 
5–10 years 2 (7.4) 
Greater than 10 years 24 (88.9) 
Number of years NICU  
Less than 2 years 1 (3.7) 
3–5 years 2 (7.4) 
5–10 years 4 (14.8) 
Greater than 10 years 20 (74.0) 
Number Years Caring for NAS  
Less than 2 years 2 (7.4) 
3–5 years 3 (11.1) 
5–10 years 6 (22.2) 
Greater than 10 years 16 (59.2) 
Moral belief influencing 
Patient care 
  
Not at all 6 (22.2) 
Minimally 13 (48.1) 
Moderately 4 (14.8) 
Significantly 4 (14.8) 
Moral beliefs influencing 
Interaction with parents 
  
Not at all 6 (22.2) 
Minimally 14 (51.8) 
Moderately 4 (14.8) 
Significantly 3 (11.1) 
 
 
 
  
Professionally satisfied 
caring for NAS newborns 
Yes 19 (70.3) 
No 8 (29.6) 
Choice of assignments   
NAS newborn 9 (33.3) 
24-week preterm 
infant 
18 (66.6) 
Care setting for  
NAS newborns 
  
Well newborn 
nursery 
0 (0) 
NICU 3 (11.1) 
Specialized care units 
for NAS 
24 (88.8) 
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When asked if moral beliefs influence their patient care 22.2% (n = 6) responded not at 
all, 48.1% (n = 13) responded minimally, 14.8% (n = 4) responded moderately, and 14.8% (n = 
4) responded significantly. For 77.7% of the participants’ moral distress to varying degrees 
influenced patient care. When asked if moral beliefs influence their interactions with parents 
22.2% (n = 6) responded not at all, 51.8% (n = 14) responded minimally, 14.8% (n = 4) 
responded moderately, and 11.1% (n = 3) responded that moral distress significantly influenced 
interactions between themselves and parents. 
The majority of participants 70.3% (n = 19) responded that they felt a professional 
satisfaction when caring for newborns with NAS, whereas 29.6% (n = 8) responded that they did 
not feel professionally satisfied. Interestingly, 66.6% (n = 18) preferred caring for 24-week 
preterm newborn rather than a newborn with NAS if given a choice in assignments, and 88.8% 
(n = 24) believed that newborns with NAS did not belong in the NICU for care. 
Analysis of the Research 
Research Question 
Do neonatal nurses experience moral distress when caring for newborns with NAS (NAS) 
whose mothers used illicit substances during pregnancy? 
The MDS-R Pediatric version was the instrument used to measure frequency and 
intensity of moral distress among neonatal nurses caring for the newborn with NAS within the 
sample population of participants. Participants had their frequency, intensity, and level of moral 
distress from self-reported responses to the instrument recorded and calculated for each of the 25 
clinical scenarios. Within descriptive statistics, examination occurred with univariate analysis 
including the frequency distribution identifying the existence (intensity) of moral distress and 
frequency among the sample participants.   
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Composite Scores of Moral Distress 
The composite score is obtained by summing each clinical scenario’s Frequency × 
Intensity Score (f × i) for each participant. Each clinical scenario has a measurement range for 
the (f × i) scores with numeric presentations from 0 to 16. This methodology of scoring identifies 
any scenario marked as never experienced or not distressing to the participant to be eliminated 
from the composite score, thus, reflecting a more accurate measurement of true moral distress. 
The resulting scores based on the 25-clinical scenario instrument contained a range of 0 to 400 as 
demonstrated through the use of the polygon in Figure 1. The mean composite moral distress 
score was 58.9 among the sample participants (n = 27) with a standard deviation of 36.4. The 
composite scores are illustrated in Table 3. All sample participants experienced varying degrees 
of moral distress. No participants had a composite score of 0, which reflected no moral distress. 
 
 
Figure 1. Question 22: Caring for newborns with NAS is not professionally satisfying.  F = 
frequency; D = intensity; M = moral distress. 
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Frequency of Moral Distress 
The mean frequency scores for the subjects ranged from 0.04 to 1.70. The instrument’s 
frequency range is identified from 0 to 4. A score of 0 identifies that the scenario never occurs, 
whereas a score of 2, 3, or 4 identifies that the scenario very frequently occurs.  
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Table 3 
All Participants Composite Scores of Moral Distress (Frequency × Intensity) 
Groups Frequency 
0–25 6 
26–51 5 
52–77 8 
78–103 7 
104–129 0 
130–155 0 
156–181 1 
 
The clinical scenario with the highest mean frequency score was 1.70, Question 25: “Interacting 
with substance misusing mothers or parents is often negative in nature due to mistrust and 
addictive behaviors demonstrated by the caregivers.” Question 25 had a mean frequency score of 
1.7 (SD = 1.2; n = 27). 
Question 23 which ranked fifth for frequency of moral distress: “Caring for newborns 
with NAS is time consuming and takes away time that should be afforded to critically ill preterm 
infants” had a mean frequency of 1.3 (SD = 1.4; n = 27). Question 22: “Caring for newborns with 
NAS is not professionally satisfying” ranked eighth for frequency with a mean of 1.19 (SD = 
1.36; n = 27). The clinical scenario means listed below ranged from 1.04 to 1.70 as shown in 
Table 4.  
Intensity of Moral Distress 
The mean intensity scores for the subjects ranged from 1.85 to 3.33. The clinical scenario 
with the highest mean frequency score was 3.33, Question 17: “Works with nurses or other 
providers who are not as competent as the child’s care requires.” The clinical scenario means 
listed below ranged from 2.81 to 3.33, as shown in Table 5. 
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Table 4 
Top-10 Clinical Scenarios: Frequency of Moral Distress 
Rank Item Mean Frequencya 
1 Question 25: Interacting with substance misusing mothers 
or parents is often negative in nature due to mistrust and 
addictive behaviors demonstrated by the caregivers.b 
1.70 
2 Question 3: Follow the family’s wishes to continue life 
support even though I believe it is not in the best interest 
of the child. 
1.63 
3 Question 17: Work with nurses or other providers who are 
not as competent as the child’s care requires. 
1.48 
4 Question 21: Work with levels of nurses or other care 
provider staffing that I consider unsafe. 
1.48 
5 Question 23: Caring for newborns with NAS is time 
consuming and takes away time that should be affording 
to critically ill preterm infants.b 
1.30 
6 Question 4: Initiative extensive life-saving actions when I 
think they only prolong death. 
1.22 
7 Question 6: Carry out the physician’s order for what I 
consider to be unnecessary tests and treatments. 
1.22 
8 Question 22: Caring for newborns with NAS is not 
professional satisfying.b 
1.19 
9 Question 20: Watch patient care suffer because of a lack 
of provider continuity. 
1.11 
10 Question 1: Provide less than optimal care due to 
pressures from administrators or insurers to reduce costs. 
Question 2: Witness healthcare providers giving “false 
hope” to parents. 
1.04 
 
1.04 
aRange = 0–4 
bNAS clinical scenario. 
 
Of note by the principal investigator was the identification that the sample participants 
frequently experienced the clinical scenarios reflective of care of the newborn with NAS, but 
these neonatal nurses did not score these scenarios to be highly intensive during their self-
reflection process in completing the moral distress instrument. The level of disturbance 
(intensity) with a score of 0 identifies no disturbance occurs, whereas a score of 3 and 4 
identifies that the scenario to a great extent disturbs the participant.  
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Table 5 
Top-10 Clinical Scenarios: Intensity of Moral Distress 
Rank Item Mean Intensitya 
1 Question 17: Work with nurses or other providers who 
are not as competent as the child’s care requires. 
3.33 
2 Question 21: Work with levels of nurses or other care 
provider staffing that I consider unsafe. 
3.15 
3 Question 1: Provide less than optimal care due to 
pressures from administrators or insurers to reduce 
costs. 
3.11 
4 Question 9: Assist a physician who in my opinion is 
providing incompetent care. 
3.04 
5 Question 10: Be required to care for patients I don’t feel 
qualified to care for. 
3.00 
6 Question 15: Take no action about an observed ethical 
issue because the involved staff member or someone in 
a position of authority requested that I do nothing. 
3.00 
7 Question 18: Witnesses diminished patient care quality 
due to poor team communication. 
3.00 
8 Question 11: Witness medical students preform painful 
procedures on patients solely to increase their skills. 
2.93 
9 Question 12: Providing care that does not relieve the 
child’s suffering because the physician fears that 
increasing the dose of pain medication will cause death. 
2.89 
10 Question 4: Initiative extensive life-saving actions when 
I think they only prolong death. 
2.81 
aRange = 0–4. 
Level of Moral Distress 
The level of moral distress scores (Frequency × Intensity) range from 0 to 16. Where the 
score of 0 reflects no moral distress is experienced and the score of 16 is the highest level of 
moral distress experienced. Clinical scenarios that have never been experienced (frequency) or 
are not perceived to be distressing (level of disturbance/intensity) do not contribute to the 
participant’s level of moral distress or to their MDS-R composite score.  
The mean level of moral distress scores for the sample participants ranged from 0.07 to 
5.07. The clinical scenario with the highest mean level of moral distress score of 5.07 was 
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Clinical Scenario Question 17: “Works with nurses of other providers who are not as competent 
as the child’s care requires.” The clinical scenario means for level of moral distress are listed 
below in Table 6. Levels of moral distress ranged from 3.15 to 5.07.  
Table 6 
Top-10 Clinical Scenarios: Level of Moral Distress (Frequency × Intensity) 
Rank Item 
Mean Level of 
Moral Distressa 
1 Question 17: Work with nurses or other providers who are 
not as competent as the child’s care requires. 
5.07 
2 Question 21: Work with levels of nurses or other care 
provider staffing that I consider unsafe. 
4.70 
3 Question 3: Follow the family’s wishes to continue life 
support even though I believe it is not in the best interest of 
the child. 
4.48 
4 Question 25: Interacting with substance misusing mothers or 
parents is often negative in nature due to mistrust and 
addictive behaviors demonstrated by the caregivers.b 
4.15 
5 Question 23: Caring for newborns with NAS is time 
consuming and takes away time that should be affording to 
critically ill preterm infants.b 
4.07 
6 Question 4: Initiative extensive life-saving actions when I 
think they only prolong death. 
3.74 
7 Question 22: Caring for newborns with NAS is not 
professional satisfying.b 
3.30 
8 Question 10: Be required to care for patients I don’t feel 
qualified to care for. 
3.26 
9 Question 1: Provide less than optimal care due to pressures 
from administrators or insurers to reduce costs. 
3.22 
10 Question 20: Watch patient care suffer because of a lack of 
provider continuity. 
3.15 
aRange = 0–16 
bNAS clinical scenario. 
 
Of the four clinical scenarios regarding NAS (Questions 22–25), two of the NAS 
scenarios—Question 25: “Interacting with substance misusing mothers or parents is often 
negative in nature due to mistrust and addictive behaviors demonstrated by caregivers” and 
Question 23: “Caring for newborns with NAS is time consuming and takes away time that 
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should be afforded to critically ill preterm infants”—were in the top five as causing moral 
distress.  For Question 25, the mean level of moral distress was 2.26 (SD = 1.26; n = 27). For 
Question 23, the mean level of moral distress was 1.85 (SD = 1.68; n = 27). One other scenario 
for NAS, Question 22: “Caring for newborns with NAS is not professionally satisfying,” was 
identified within the top 10 producing moral distress in this sample group with a mean of 1.85 
(SD = 1.51; n = 27). 
Additional Statistical Analysis of Data 
The principal investigator wished to explore the possibility that neonatal nurses caring for 
newborns with NAS whose mothers used illicit substances during pregnancy experienced moral 
distress. Figures 1 through 4 illustrate the responses to the NAS Clinical Scenario Questions 22 
through 25 within the instrument in a histogram. Results revealed that interacting with substance 
misusing mothers and caregivers produced the highest levels of moral distress among the 
identified NAS scenarios within the sample group of study participants.  
 
Figure 2. Question 23: Caring for a newborn with NAS is time consuming and takes away time 
that should be afforded to critically ill preterm infants. F = frequency; D = intensity; M = moral 
distress. 
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Figure 3. Question 24: My critical care skills are wasted on caring for newborns with NAS. F = 
frequency; D = intensity; M = moral distress. 
 
 
Figure 4. Question 25: Interacting with substance misusing mothers/parents is often negative in 
nature due to mistrust and addictive behaviors demonstrated by caregivers. F = frequency; D = 
intensity; M = moral distance. 
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Also of interest was the possibility for any correlational relationship between years caring 
for newborns with NAS, as well as years working in the NICU and levels of frequency, intensity, 
and moral distress, respectively. Tables 7 and 8 demonstrate the lack of clinical significance for 
the p value. The principal investigator’s testing did not reach a p value of < .05 and therefore, no 
significant relationship was established with regards to years working in a NICU or years caring 
for newborns with NAS. 
Table 7 
Correlations Between Either Frequency, Intensity, or Moral Distress of Selected Scale Items and 
Subjects’ Years Caring for Newborns With NAS 
 
Item 
Frequency 
r/p 
Intensity 
r/p 
Moral Distress 
r/p 
Question 22: Caring for newborns with 
NAS is not professional satisfying. 
.275/.165 .088/.661 .265/.181 
Question 23: Caring for newborns with 
NAS is time consuming and takes away 
time that should be affording to 
critically ill preterm infants. 
.265/.181 .056/.783 .258/.194 
Question 24: My critical care skills are 
wasted on caring for newborns with 
NAS. 
.189/.346 -.095/.639 .096/.633 
Question 25: Interacting with substance 
misusing mothers or parents is often 
negative in nature due to mistrust and 
addictive behaviors demonstrated by the 
caregivers. 
-.108/.592 -.201/.314 -.135/.502 
 
The principal investigator included one open-ended question to allow participants to 
reflect upon their responses within the demographic questionnaire. Not all participants responded 
to this question but of those that did, the principal investigator embraced and appreciated the 
honesty as well as the identification of moral distress these nurses are experiencing. 
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Table 8 
Correlations Between Either Frequency, Intensity, or Moral Distress of Selected Scale Items and 
Subjects’ Years in the NICU 
 
Item 
Frequency 
r/p 
Intensity 
r/p 
Moral Distress 
r/p 
Question 22: Caring for newborns 
with NAS is not professional 
satisfying. 
.285/.149 .108/.593 .202/.313 
Question 23: Caring for newborns with 
NAS is time consuming and takes away 
time that should be affording to 
critically ill preterm infants. 
.214/.283 .039/.845 .161/.422 
Question 24: My critical care skills are 
wasted on caring for newborns with 
NAS. 
.310/.115 .077/.702 .269/.175 
Question 25: Interacting with substance 
misusing mothers or parents is often 
negative in nature due to mistrust and 
addictive behaviors demonstrated by the 
caregivers. 
-.127/.527 -.121/.549 -.046/.818 
 
Participant responses are included below. 
Participant 1 wrote: “I prefer the quick pace of critical care. I dread going into work and 
seeing if I have a NAS patient (no RN satisfaction). I don’t like the monotony and repetition of 
NAS kids.” 
Participant 16 wrote: “Sometimes I feel useless trying to comfort NAS babies. I also have 
trouble dealing with parents who are manipulative and/or angry.”  
Participant 19 wrote the following:  
A 24-weeker is usually less stressful to me, they aren’t constantly screaming. I hate 
putting down a baby to cry to take care of another baby in my assignment. Parents can 
see how sick a tiny baby is—but they do not know what is wrong with the NAS baby—it 
looks like we just let them cry. 
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Participant 21 wrote: “It is stressful to nurses to have a baby with lines, etc. . . . . and, a 
NAS baby.” 
Participant 23 wrote: “I prefer less high-tech stress. I find caring for and teaching parents 
about NAS rewarding.” 
Participant 25 wrote the following:  
As a parent of a child with drug addiction I only want to help these babies. I feel they are 
the victims of awful circumstances. In a perfect world there could be a special unit for 
these families with drug addiction but the world is not perfect so we have to do the best 
we can.  
Summary 
The principal investigator through the use of a pilot study explored if moral distress is 
experienced by neonatal nurses caring for newborns with NAS whose mothers used illicit 
substances during pregnancy. The use of a descriptive design allowed the principal investigator 
to describe the phenomena of moral distress within the care of newborns with NAS. The results 
of this research study revealed that indeed, neonatal nurses experience moral distress to varying 
degrees within the NICU setting. Caring for newborns with NAS within this sample participant 
group produced moral distress especially when these nurses interacted with substance misusing 
mothers and care givers. Although not all neonatal nurses caring for newborns with NAS and/or 
interacting with substance misusing caregivers experienced moral distress the review of the data 
is imperative for identifying strategies to support nurses universally to prevent/address moral 
distress in the NICU. 
Three categories of root causes for moral distress have been identified in the literature: 
clinical situations, factors internal to the health care professional, and external constraints in a 
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particular situation or health care environment (Corley, 2005; Hamric et al., 2012). Root causes 
originating from clinical situations generate moral distress among critical care nurses. Internal 
constraints refer to the personal characteristics of the nurse, where he/she may feel powerless or 
has not developed assertiveness communication techniques limiting their ability to vocalize their 
concerns/opinions in a distressing situation. External constraints are born through the health care 
facility whether it is a philosophy or “culture” not conducive to the nurse’s moral standing or a 
perception that care may be compromised due to cost/staffing constraints, as well as following 
family wishes for fear of retaliation/litigation when not in the best interest of the patient (Elpern 
et al., 2005). 
While the NAS clinical scenarios produced moral distress in this sample the principal 
investigator would be remiss if a description of the other scenarios were not analyzed for 
triggering moral distress in this sample of participants. Table 9 is representative for Clinical 
Scenario 17: “Works with nurses or other providers who are not as competent as the child’s care 
requires,” was the leading scenario causing intensity of moral distress as well as the overall level 
of moral distress. This scenario was identified as the third most experienced within the frequency 
parameter. Clinical Scenario 21: “Works with levels of nurses or other care provider staffing that 
I feel is unsafe,” was the second highest producer of overall moral distress as well as the 
intensity marker. This question also ranked as the fourth top scenario experienced through 
frequency of moral distress. Clinical Scenario 3: “Follow the family’s wishes to continue life 
support even though I believe it is not in the best interest of the child,” was the third leading 
cause of overall moral distress, and the second most experienced scenario but this experience 
was not appreciated to be intensely experienced among this sample of neonatal nurses.  
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Table 9 
Clinical Scenario 17 
Level Frequency Intensity 
0 3 (11.1%) 0 (0%) 
1 15 (55.5%) 1 (3.7%) 
2 3 (11.1%) 1 (3.7%) 
3 5 (18.5%) 13 (48.1%) 
4 1 (3.7%) 12 (44.4%) 
 
Neonatal intensive care units are high-intensity environments where technology and a 
variety of patient populations may be morally and emotionally burdensome to the neonatal nurse. 
Caring for a diverse population of patients which now includes newborns with NAS as well as 
interacting with parents of addiction has not been common place to this health care setting. The 
limited evidence within bodies of research suggests that neonatal nurses are at risk for 
experiencing moral distress when caring for newborns with NAS and may benefit from increased 
awareness and identification of strategies to prevent and treat this phenomenon of distress. 
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CHAPTER FIVE: DISCUSSION 
Maternal substance use/misuse during pregnancy may lead to adverse neonatal outcomes, 
including NAS. The incidence of NAS is directly related to the increasing rates of maternal 
misuse/use of both illicit and licit substances during her pregnancy. The care of the newborn with 
NAS is one of the most challenging conditions for the neonatal nurse. Management of these 
newborns requires knowledge that has not been traditionally partnered within care in the NICU. 
Understanding addiction, addictive behaviors, and the psychological needs of substance abusing 
parents has not been commonplace in the NICU setting. Caring for the newborn with NAS and 
interacting with addicted mothers/parents may present ethical and moral dilemmas for the 
neonatal nurse. Identifying neonatal nurses’ perceptions, including moral beliefs, and specific 
educational needs regarding addiction and chemical dependence may provide specific creation 
for interventions to promote the nurses’ mental well-being while providing a positive interaction 
between the neonatal nurse and mother. 
As doctors of nursing practice, our role encompasses organizational changes to remove 
barriers to care and improve patient outcomes. Structural stigmata are barriers to care; no one in 
health care will dispute that fact. These stigmata restrict assistance options available to 
patients/clients that are categorized as part of a stigmatized group; the principal investigator here 
is addressing the vulnerable group of women who misuse/abuse substances and struggle with 
addiction (Fonti et al., 2016; Livingston et al., 2011). Research has demonstrated that when these 
mothers feel like they are not being judged and interactions are humane and kind they bond more 
easily with their newborns giving them confidence to strengthen the attachment process and 
succeed in competently caring for their newborn (Catlin, 2012; Marcellus, 2014; Muhuri & 
Gfoerer, 2009). 
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Discussion of Findings 
Neonatal Nurses and Moral Distress 
While moral distress has been studied in nurses for close to 20 years, emerging research 
in the last 5 years or so has focused on moral distress in the NICU setting including the clinical 
scenarios that may be triggers to the development of moral distress. Nurses who experience 
moral distress may lose their capacity for caring, avoid patient contact, and consider leaving the 
nursing profession (American Association of Critical Care Nurses, 2008). Moral distress has 
implications for job dissatisfaction, retention, and may negatively impact the delivery of 
safe/competent care to our patients/clients (Cavaliere et al., 2010; Varcoe, Pauley, Webster, & 
Storch, 2012; Wiegand & Funk, 2012). Moral distress has become a growing concern in the 
NICU setting due to the complexity and fragility of neonates; as well as the new health care 
dilemma regarding addiction. Maternal addiction and newborns with NAS has reached epidemic 
proportions in the United States and across the globe (McQueen & Murphy-Oikonen 2016; 
Patrick et al., 2015; Prentice, Janvier, Gillam, & Davis, 2016; Tolia, Patrick, Bennett, & Monica, 
2015). 
Within the sample participants there were varying levels of moral distress related to the 
identification of the clinical scenarios proposed within the MDS-R instrument. Moral distress is a 
subjective phenomenon; therefore not every nurse will experience the same degree of moral 
distress within every clinical scenario described within the instrument. This statement holds true 
for this purposive sample of participants.  
NAS Clinical Scenarios and Moral Distress 
The NAS clinical scenarios were in the top 10 scenarios that produced moral distress for 
this group of neonatal nurses when compared to all 25 of the clinical scenarios. Also of note was 
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the identification that interacting with substance misusing mothers happened frequently among 
this sample but not intensely. Neonatal nurses may experience conflict in developing rapport 
with mothers suffering from addiction or recovery due to the caregiver’s lack of understanding 
and knowledge regarding addiction (Fraser et al., 2007; Maguire et al., 2012; Shaw et al., 2016). 
Without the ability to understand and empathize with the addicted mother/parents, neonatal 
nurses may experience frustration, and anger towards the mother whose infant is suffering as a 
result of maternal addictive behaviors (Fraser et al., 2007). The neonatal nurse who lacks 
empathy may be unintentionally contributing to failure of establishment of the mother/infant 
bond (Fraser et al., 2007). Nurses who lack an understanding of maternal experiences with 
addiction and recovery may reinforce negative behaviors such as irregular visiting patterns and 
lack of trust (Cleveland & Bonugli 2014; Cleveland & Gill, 2013; Hill, 2013).  
 The NICU nurse must contend with the personal ethical obligations to provide the best 
care to the newborn experiencing NAS while providing support and guidance to the addicted 
mother/parents (Maguire et al., 2012). Absence of the mother, the severity of the newborn’s 
withdrawal, and complexity of care may all contribute to distress, frustration, and moral 
dilemmas for the neonatal nurse (Fraser et al., 2007; Murphy-Oikonen et al., 2010). 
The neonatal nurse generally speaking expresses genuine empathy when caring for the 
medically fragile newborns and supports those caregivers. This sample population demonstrated 
an interest in caring for the 24-week preterm neonate over the care of the newborn with NAS 
when given a choice of patient assignments; the majority of these participants also believe that 
these newborns should not be cared for in the NICU but rather a specialized unit for newborns 
experiencing withdrawal. The views of these sample participants have been supported in the 
literature with earlier studies within the last 5 years exploring feelings, perceptions, and 
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interactions of neonatal nurses and addicted mothers/caregivers (Cleveland & Bonugli, 2014; 
Cleveland & Gill, 2013; Hill, 2013; Maguire et al., 2012; Shaw et al., 2016). 
Recent studies have indicated that there are strained relationships between the neonatal 
nurse and the addicted mother (Fraser et al., 2007; Maguire et al., 2012; Murphy-Oikonen et al., 
2010). In each of these studies, neonatal nurses expressed genuine caring towards these 
newborns and their desire to provide quality care to the newborns during their withdrawal, but 
expressed frustration and moral distress when they were not able to console or comfort the 
newborn. Within previous bodies of research other themes which were identified by the 
participants included beliefs that newborns with NAS did not require specialized care in the 
NICU and that the environment is too busy and overstimulating for those newborns. Some nurses 
verbalized their beliefs that newborns with NAS are not sick enough to warrant critical care as 
well as the frustration they felt when the babies were inconsolable with high pitched crying. 
These babies are difficult to comfort leaving the neonatal nurse with feelings of frustration and 
burnout when caring for the newborn with NAS (Murphy-Oikonen et al., 2010). 
Demographic Variables and Influence on Moral Distress 
Several studies during the past decade have explored specific demographic characteristics 
and their association to trigger feelings of moral distress. Some studies have established a 
relationship where nurses who are older, working with more experience, and who have been 
employed in a specific position for several years are frequently confronted with moral distress 
(Mobley, Rady, Verheijde, Patel, & Larson, 2007; Rice, Rady, Hamrick, Verheijde, & 
Pendergast, 2008); while other researchers did not identify a specific association or correlational 
relationship (Cavaliere et al., 2010; Corley et al., 2001; McAndrew, Leske, & Garcia, 2011; 
Pauley, Varcoe, & Storch, 2009). Within the same or similar bodies of research there were 
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variations regarding the association for intensity of moral distress within the previously 
described demographic variables (Cavaliere et al., 2010; Kain, 2007; Sannino, Gianni, Re, & 
Lusignan; Yam, Rossiter, & Cheung, 2001). 
Nurses experienced moral distress more frequently when they perceived a negative 
ethical climate in the unit in which they worked, when they felt obliged to perform tasks or carry 
out provider orders that were perceived to not be in the best interest of the patient; especially 
when care was recognized to be futile (Cavaliere et al., 2010; Corley et al., 2001; Corley et al., 
2005; Ganz & Berkovitz, 2012; Hamric & Blackhall, 2007; McAndrew et al., 2011; Pauley et al., 
2009). Nurses experienced a higher intensity of moral distress when they were exposed to 
negative ethical climates such as working with incompetent staff, futile care, and uncooperative 
behaviors of a patient and/or family member (Cavaliere et al., 2010; Corley et al., 2005; 
McAndrew et al., 2011; Pauley et al., 2009; Rice et al., 2008). Within this sample, the neonatal 
nurses’ top three clinical scenarios producing moral distress were working with incompetent 
staff, inadequate staffing assignments as well as providing care perceived to be futile. 
Corley’s Theoretical Framework of Moral Distress 
The theoretical framework chosen by the principal investigator despite being created over 
10 years ago remains efficacious in describing moral distress among health care professionals; 
especially critical care nurses. Dr. Corley began her research on critical care nurses in the mid-
1990s. Much of Dr. Corley’s research parallels Jameton’s research on nursing and moral distress. 
Corley’s research became the foundation for her proposed theory of moral distress. Corley 
theorized that moral distress occurs among nurses when nurses know what is best for the patient 
but his/her course of action may conflict with the organization, his/her colleagues, the family 
structure or society as a whole. 
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Therefore, moral distress may occur when nurses’ values and perceived obligations are 
not compatible with structural views or the work environment (Corley, 2002). Stated simply, 
Corley identifies the presence of moral distress when a nurse either is unable or perceives he/she 
is unable to advocate for his/her patient. Moral distress occurs as both an internal and external 
context. The external context includes the work environment, lack of leadership or physician 
support and facility framework limitations. The internal context of moral distress is related to the 
professional nurse’s psychological responses, for example, does the nurse develop feelings of 
low self-esteem, powerlessness to advocate for the patient, and has stress begun to affect his/her 
personal/professional life. 
Moral distress occurs when the nurse experiences feelings or perceives that his/her 
personal integrity is being threatened. Corley (2002) recognized that moral distress can be 
devastating to nurses leading to burn out, leaving the profession of nursing altogether and may 
have a negative impact on patient care. Corley’s theory is based on two foundations: (a) the 
science and art of nursing is one of a moral profession; and (b) nurses because of who they are, 
become moral agents. Corley’s framework of moral distress guided this study addressing moral 
distress among this sample group of neonatal nurses caring for newborns with NAS whose 
mothers used illicit substances during pregnancy. Maternal addition and lack of knowledge 
among nurses regarding addiction may limit them from behaving in accordance with their 
conceptual ideals and ethical moral beliefs. Corley’s framework addresses internal, external, and 
the subjectivity of moral distress among critical care nurses.  
Limitations of the Study 
Although the sample participants had a greater than 50% response rate with 27 of the 44 
available nurses participating; the sample size is small. Due to the small sample size correlational 
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statistics between demographic characteristics and relationship to moral distress were not 
statistically meaningful. Of note, when large sample sizes were present in studies researchers 
noted varying results for correlational relationships for demographic characteristics and levels or 
presence of moral distress. 
Despite that participation was anonymous and completely voluntary; the principal 
investigator postulated that lack of participation from some of the neonatal nurses may have been 
due to perception that moral distress is not important or because engaging in completing the 
instrument requires self-reflection. This self-reflection may validate that indeed, the participant is 
experiencing moral distress but he/she is not prepared to address the moral conflicts they are 
experiencing. Therefore, the data analyzed mirrors the views of those neonatal nurses who chose 
to participate only. 
Characteristics reflected within the demographic findings may also have limited the study 
results not allowing for generalization to larger sample population. The neonatal nurses were 
from a single health care facility within a specific geographic area, similar in age, years working 
with newborns with NAS, and levels of nursing education. Within the studied setting this NICU 
may experience 50% of the census of patients with a diagnosis of NAS at any given time. Other 
NICUs regionally may not experience the high census of these newborns possibly altering 
participant group responses/perceptions for levels of moral distress and the clinical scenarios 
triggering the cascade of moral distress. Also of note the principal investigator was employed as 
a neonatal nurse practitioner within the healthcare facility and her presence/role may be seen as a 
limitation. 
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Parental perspectives on the negative interactions or negative societal judgements due to 
addiction are an important component of caring for the newborn with NAS but are beyond the 
scope of this study. 
Implications for Nursing Practice and Education 
Newborns with NAS are frequently cared for by neonatal nurses. Neonatal nurses may 
experience conflict in developing a rapport with mothers suffering from addiction or recovery 
due to the professional caregiver’s lack of understanding, empathy, and knowledge regarding 
addiction (Fraser et al., 2007; Maguire et al., 2012; Raeside, 2003; Shaw et al., 2016). Without 
the ability to understand and empathize with the addicted mother, nurses may experience 
frustration and anger toward the mother whose newborn is suffering as a result of their addictive 
behaviors (Fraser et al., 2007). The neonatal nurse who lacks empathy may be unintentionally 
contributing to the failure of establishment of the mother/infant attachment (bonding) process 
(Fraser et al., 2007). Nurses who lack an understanding of maternal experiences with addiction 
and recovery may reinforce negative behaviors such as regular visiting patterns and lack of trust 
(Cleveland & Bonugli, 2014; Cleveland & Gill, 2013; Hill, 2013). The NICU nurse must contend 
with personal ethical obligations to provide the best possible care to the newborn experiencing 
NAS while providing support and guidance to the addicted mother/caregivers (Maguire et al., 
2012). Recent studies have identified a lack of empathy and sensitivity towards parents who are 
struggling with addiction (Maguire et al., 2012; Murphy-Oikonen et al., 2010). Nursing 
management of NAS requires knowledge not traditionally associated within the NICU, such as 
the physiological changes that occur as an integral part of the addiction process, social risk 
behaviors, and psychological needs of parents with substance misuse or addictive complexities 
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(Maguire, 2014; Sakar & Donn, 2006; Shaw et al., 2016). Nurses who care for and interact with 
mothers and newborns exposed to illicit substances face complex challenges on a daily basis.  
Important identification of interventions for alleviating moral distress among these 
professional care givers is paramount. Education is warranted regarding triggers of addiction, 
chemical changes that occur within the addiction patients’ brain/physiology, and collaboration 
among the interprofessional health care team members. Ongoing education through nursing, 
addiction counselors, social workers, and community leaders provides for a unique opportunity 
to educate health care professionals and more importantly develop a comprehensive care model 
for childbearing women suffering from addiction. 
In this health care organization newborns with NAS will continue to be cared for in the 
NICU. Sample participants overwhelming identified that these newborns need to be cared for in 
a specialized unit specifically to meet the needs of the newborns and support the addicted 
parent/parents. The participants also spoke to the fact that these newborns cry incessantly and 
cannot be soothed easily making it emotionally difficult to put the baby down while crying in 
their crib in order to attend to another patient within their assignment.   
The principal investigator had previously suggested the formation of a “cuddle 
companions” service to assist in the care of these newborns. Nursing leadership within the 
maternal child division of the sample hospital were responsible for the formation of such a 
system. This program includes a specific set of volunteers who are trained to understand NAS 
and how to comfort and settle these complex newborns. Companions will be able to interact with 
this specific set of newborns with parental consent and will be available on call 24/7 when 
newborns with NAS are admitted to the NICU. Scheduling someone to be with the newborn that 
is withdrawing for most hours of the day will assist the neonatal nurse in the soothing and 
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comfort care aspects that have been frustrating for them because there is not enough time to sit 
with these newborns. Another important function of this companion system is enhancing 
interactions between the parents and the neonatal nurses. A daily schedule was recommended by 
the principal investigator to be formulated and agreed upon between staff and parents to ensure 
that a soothing caregiver whether parent, nurse or cuddle companion is available for the newborn 
with NAS. 
Longitudinal studies are lacking in the literature regarding following critical care nurses 
after moral distress has been identified. After the cuddle companion program has been in place 
for a year the principal investigator would like to return to this same NICU setting after 
Institutional Review Board approval is granted and again through anonymous, voluntary 
participation have the MDS-R moral distress instrument completed again. The principal 
investigator postulates that the introduction to this new model of care will decrease the frequency 
and level of moral distress noted in the initial analysis of data. A cuddle companion would be 
assigned to a specific newborn to assist in the consoling while providing the identified non-
pharmacologic therapies such as rocking, soft voices, swaddling, and cuddling of the newborn 
experiencing withdrawal. 
One of the keys to addressing moral distress is to understand how time and evolving 
patient care populations along with technological advances alters the workplace environment for 
neonatal nurses. Nurses who do not alleviate or cope with their distress may indeed leave the 
NICU for less stressful patient care environments. Interventions related to care and removal of 
barriers for effective work flow to care will enhance patient care and professional satisfaction for 
the NICU nurse. 
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Implications for Nursing Leadership and Policy 
Sources of moral distress may involve personal, interprofessional, and environmental 
conflicts for the critical care nurse. Creating a work environment that is healthy for both the 
nurse and patient will promote positive interactions between the nurse and patient/caregivers and 
improve patient outcomes. The American Association of Critical Care Nurses has a very clear 
call to action and policy position for addressing moral distress within a healthcare setting. This 
policy speaks to the self-reflection of the staff nurse, what triggers he/she feels promotes moral 
distress, and implementation of strategies to remove distress through education, counseling, and 
development of guidelines for the care of newborns with NAS and end of life care for the 
critically ill neonate. 
Development of medical and nursing guidelines for the care of these two vulnerable/ 
fragile populations of newborns will increase consistency in care, reinforce education in caring 
for these newborns and allow neonatal nurses to be a voice in developing and implementation of 
the new policy care guidelines. Consistency in accepted care guidelines may decrease feelings of 
newborns not being cared for competently. 
Nursing leadership within the health care organization should recognize that neonatal 
nurses are experiencing moral distress and develop ongoing strategies to assist in educating, 
supporting, and counseling these nurses when moral distress occurs for them either individually 
or as a team after a distressing event occurs within the NICU. Following the AACN guidelines in 
regards to the implementation of employee assistance programs, debriefings, and counseling 
sessions may alleviate degrees of distress for the critical care nurses. The identification of moral 
distress and then providing ongoing support and tools to manage distress is important to prevent 
burnout and decreases negative interactions between nurses and patients, families, and other 
  
78 
health care colleagues. Promotion of a healthy work environment should be a priority within all 
frameworks of administrative leadership in all health care facilities.  
Implications for Future Research 
Moral distress develops when a nurse perceives their ethical standards or values are not 
shared with or do not align with other health care team members (Epstein & Delgado, 2010). 
Research has demonstrated that there are several factors within clinical scenarios that may lead 
to moral distress for neonatal nurses. One such clinical scenario is caring for newborns with NAS 
and interacting with parents suffering from addiction. Doctor of nursing practice-prepared nurses 
have the ability to replicate this study on a larger scale by seeking responses from the 
professional organizations that serve the neonatal nursing population. These organizations 
through their education and policy committees would be able to develop a framework with a 
standardized approach for care of newborns with NAS, techniques for improving communication 
during interactions with addicted parents as well as resources for neonatal nurses to assist them 
when dealing with a sensitive or morally distressing issue. 
Research is also needed in regards to where to appropriately care for these newborns; 
clearly the NICU environment is too intensive for these newborns that need a quiet, soothing 
setting for care. Addressing maternal addiction and removing barriers to care will also improve 
health care of both the mother and her unborn child. Access to care and to addiction counseling 
therapies will surely help to decrease the epidemic of newborns suffering with NAS born 
annually in the United States and abroad. 
Summary 
Defining moral distress and developing interventions to address and treat these negative 
experiences is imperative to the physical and mental health of every neonatal nurse. Longitudinal 
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studies may provide valuable insight on clinical scenarios in regards to real-life frequency, 
intensity, as well as over levels of moral distress. This information provides a framework to 
formulate an ethical climate of care for both the neonatal nurse and the patients/families he/she 
may care for suffering from addiction etiologies. 
Conclusion 
The prevalence of maternal substance misuse in the United States continues to rise 
annually. Patterns of change due to exposure now for poly substance misuse makes it difficult to 
care for the newborns exposed who develop NAS when they are born. The increased incidence 
of NAS and the complexity of care in NICUs partners with an associated increase in health care 
costs mostly funded by state Medicaid programs. Innovations to care will improve access of care 
for mothers suffering with addiction, their newborns and our health care system.   
Primary prevention strategies are needed to address this epidemic and to decrease the 
incidence of NAS. Creating a compassionate, caring, and non-judgmental environment for the 
women of childbearing age is important. A positive health care environment where mothers do 
not feel stigmatized and guilty because of their addiction improves health care for both her and 
her unborn child and fosters positive attachment to the newborn in the postpartum period (Hill, 
2013; Hogan, 2007). 
Caring for newborns with NAS requires an understanding of addiction, how to interact 
with caregivers suffering from addiction as well as time management to care for all assigned 
patients within the NICU. Clearly, care for newborns with NAS is an ethically charged scenario 
that may produce moral distress for some neonatal nurses. If the neonatal nurse is experiencing 
feelings of distress morally from their encounters with addicted mothers then they are 
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overwhelmed and frustrated because they cannot adequately care for the patients within their 
daily NICU assignments as evidenced within this present body of research. 
Through nursing research; the identification of nurses’ perceptions, including beliefs, 
biases, and specific educational needs for providing effective nursing care for pregnant women 
and parenting women who misuse illicit substances will improve the quality of care by providing 
a scientific foundation for clinical practice. Scholarship through nursing research provides our 
profession with new knowledge relevant to developing frameworks of care for both our patients 
and fellow nursing colleagues. 
Moral distress as described by Dr. Mary Corley occurs when personal, professional, or 
environmental constraints pose ethical dilemmas to the critical care nurse. Through this body of 
research, clinical scenarios of working with incompetent staff/colleagues, interacting with 
substance misusing mother and futility of end of life care have been described as triggers within 
this sample group of research participants. When moral distress is not addressed critical care 
nurses may experience moral residue related to emotional exhaustion and depersonalization both 
for themselves and the patients in which they care for as well as burnout (Oh & Gastmans, 
2015). 
The finding concerning the participants perception that colleagues were not competent to 
care for certain critical patients is concerning (low quality of care) as a cause of moderate to high 
distress has also been reported in Dr. Corley’s work (Corley, 2002; Corley et al., 2005). Several 
studies have demonstrated that moral distress affects nurse, leading to a decreased motivation 
and reduction of the ability to provide optimal patient care. Furthermore, nurses tend to escape 
from fostering positive relationships between patients and family members quite possibly losing 
their art of caring. The experiences of moral distress is accentuated when lack of resolution 
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occurs and burnout ensues without lack of support, mentoring/counseling because of institutional 
constraints, interprofessional conflicts and legal obligation towards care (Cavaliere et al., 2010; 
Corley et al., 2001; Corley et al., 2005; Gutierrez et al., 2005). 
Although morally distressing experiences may not be frequent, they have a significant 
impact on the neonatal nurse when they do occur. Some nurses may experience moral distress 
even when the scenario has passed but their conflict is unresolved or they are again exposed to a 
scenario without previous resolution, as seen with moral residue or a crescendo effect (Pauley et 
al., 2009). Evidence-based practices and interventions to alleviate moral distress and moral 
residue from the work environment is imperative for a critical care nurse. Moral distress and 
residue may negatively impact one’s psycho-emotional responses and nursing practice by 
internalizing the problem. It is manifested by guilt, shame and self-blame. Nurses who 
experience moral distress and moral residue and continue to work tend to withdraw from patient 
care and become distrustful of their professional colleagues (Gutierrez et al., 2005). 
Several studies have demonstrated that moral distress affects nurses, leading to a 
decreased motivation, and reduction of the ability to provide optimal patient care. Furthermore, 
nurses tend to escape from fostering positive relationships between patients and family members 
quite possibly losing their art of caring. The experiences of moral distress is accentuated when 
lack of resolution occurs and burnout ensues without lack of support, mentoring/counseling 
because of institutional constraints, interprofessional conflicts and legal obligation towards care 
(Corley et al., 2001; Corley et al., 2005; Cavaliere et al., 2010; Epstein et al., 2009; Gutierrez et 
al. 2005). 
Reviewing the research literature and conducting this body of research uncovered the gap 
in both understanding moral distress for neonatal nurses as well as the lack of knowledge 
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regarding maternal addiction therefore hindering therapeutic interactions and/or relationships. 
Neonatal nurses are the key primary caregivers not only for the newborn with NAS but play an 
important role in “mothering” the woman who is suffering from addiction and guilt. Empowering 
mothers in a non-judgmental, caring and empathetic environment will foster trust and 
interactions will support the promotion of attachment between mother and child.   
Neonatal nurses are important voices for identification and strategies to combat moral 
distress, guide policies and establish evidenced based protocols for consistent care for newborns 
with NAS and their parents. Neonatal nurses serve as the liaison for parents and newborns 
preparing to transition to home and community outpatient services in order to facilitate safe, 
loving home environments for both the mother and newborn with NAS. 
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Appendix C: Introductory Letter 
Dear Neonatal Nurse Colleague, 
 My name is Valarie Artigas and I am a Doctor of Nursing Practice student at the 
University of Connecticut.  In partial fulfillment for completing my degree, I am conducting a 
pilot study to explore if moral distress is experienced by neonatal nurses when caring for 
newborns with neonatal abstinence syndrome (NAS) whose mothers used illicit substances 
during pregnancy.  The purpose of the research study is to understand the moral conflicts and 
moral distress that may occur during care of the newborn with NAS. 
 
 The body of research thus far has explored the presence of moral distress at end of life 
care and futile care measures in neonatal nursing when caring for our fragile patient population.  
As neonatal health care professionals we realize the epidemic proportions of maternal addiction 
which results in newborns being born exhibiting varying degrees of substance withdrawal. 
 
 As a neonatal nurse you are being asked to partake in this voluntary and anonymous 
study. Your input and self-reflection responses will contribute greatly to understanding how 
neonatal nurses feel when caring for the newborn with NAS.  Your participation will involve 
completion of a demographic questionnaire and the moral distress scale.  Risks of participation 
in the study are minimal.  If during self-reflection a question is of a sensitive nature you may 
defer answering that question and continue on with your other responses. The attached 
questionnaire and moral distress scale will take approximately 25 minutes to complete.  All 
responses will be anonymous and confidential.  Please do not place your name on any of the 
demographic or moral distress scale forms.  If you wish to participate please complete and 
return your survey to the secured NICU response box found in the staff mailbox room. 
 
 While there is no direct benefit to you from your voluntary participation in the study, 
understanding how neonatal nurses feel during care of the NAS newborn may improve 
identification and intervention configurations to alleviate moral distress in the Neonatal Intensive 
Care Unit (NICU).  You may choose not to participate in the study if you so desire without 
penalty.  Results of the study may be published in scholarly journals or be presented at 
professional conferences.  A small box of chocolates is provided to express my appreciation for 
your time and support.  If you have any questions please feel free to contact me at:  
valarie.artigas@uconn.edu. 
 
Sincerely, 
Valarie Artigas, MSN, NNP-BC 
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Appendix D: MDS-R Pediatric Version 
 
Nurse Questionnaire (Pediatric) 
 
Moral distress occurs when professionals cannot carry out what they believe to be ethically 
appropriate actions because of internal or external constraints. The following situations occur in 
clinical practice.  If you have experienced these situations they may or may not have been morally 
distressing to you.  Please indicate how frequently you experience each item described and how 
disturbing the experience is for you. If you have never experienced a particular situation, select “0” 
(never) for frequency.  Even if you have not experienced a situation, please indicate how disturbed 
you would be if it occurred in your practice.  Note that you will respond to each item by checking 
the appropriate column for two dimensions:  Frequency and Level of Disturbance. 
 
 
Frequency Level of Disturbance 
Never           Very Frequently                   None                    Great extent 
                                       
0 1 2 3 4 0 1 2 3 4 
1. Provide less than optimal care due to pressures from administrators 
or insurers to reduce costs. 
          
2. Witness healthcare providers giving “false hope” to parents.           
3.  Follow the family’s wishes to continue life support even though I 
believe it is not in the best interest of the child.   
          
4.  Initiate extensive life-saving actions when I think they only prolong 
death.  
          
5.  Follow the family’s request not to discuss death with a dying child 
who asks about dying.  
 
          
6.  Carry out the physician’s orders for what I consider to be 
unnecessary tests and treatments. 
 
          
7.  Continue to participate in care for a hopelessly ill child who is being 
sustained on a ventilator, when no one will make a decision to 
withdraw support. 
          
8.  Avoid taking action when I learn that a physician or nurse colleague 
has made a medical error and does not report it. 
          
9.  Assist a physician who in my opinion is providing incompetent 
care. 
          
10. Be required to care for patients I don’t feel qualified to care for. 
 
          
11.  Witness medical students perform painful procedures on patients 
solely to increase their skill. 
          
12.  Provide care that does not relieve the child’s suffering because the 
physician fears that increasing the dose of pain medication will cause 
death. 
          
13.  Follow the physician’s request not to discuss the child’s prognosis 
with parents. 
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Frequency 
 
Level of Disturbance 
Never           Very Frequently                   None                Great extent 
                                       
0 1 2 3 4 0 1 2 3 4 
14.  Increase the dose of sedatives/opiates for an unconscious child that 
I believe could hasten the child’s death. 
 
          
15.  Take no action about an observed ethical issue because the 
involved staff member or someone in a position of authority requested 
that I do nothing. 
 
          
16.  Follow the family’s wishes for the child’s care when I do not agree 
with them, but do so because of fears of a lawsuit. 
          
17.  Work with nurses or other providers who are not as competent as 
the child’s care requires. 
 
          
18.  Witness diminished patient care quality due to poor team 
communication. 
          
19.  Ignore situations in which parents have not been given adequate 
information to insure informed consent. 
          
20. Watch patient care suffer because of a lack of provider continuity.           
21. Work with levels of nurse or other care provider staffing that I 
consider unsafe. 
          
22. Caring for newborns with NAS is not professional satisfying. 
 
          
23. Caring for newborns with NAS is time consuming and takes away 
time that should be afforded to critically ill preterm infants. 
 
          
24. My critical care skills are wasted on caring for newborns with 
NAS. 
 
          
25. Interacting with substance misusing mothers or parents is often 
negative in nature due to mistrust and addictive behaviors 
demonstrated by the caregivers. 
 
          
If there are other situations in which you have felt moral distress, 
please write them and score them here: 
          
 
Have you ever left or considered quitting a clinical position because of your moral distress with 
the way patient care was handled at your institution? 
 
No, I’ve never considered quitting or left a position ______ 
Yes, I considered quitting but did not leave ______ 
Yes, I left a position ______ 
 
Are you considering leaving your position now?   Yes  No 
 
© 2010, Ann Baile Hamric, All Rights Reserved.  
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Appendix E: Demographic Questionnaire 
DEMOGRAPHIC QUESTIONNAIRE 
Do neonatal nurses experience moral distress when caring for newborns with Neonatal 
Abstinence Syndrome (NAS) whose mothers used illicit substances during pregnancy? 
Please read each question.  Place a check in the corresponding response circle. 
1.  What is your present age? 
o 20-29 years of age 
o 30-39 years of age 
o 40-49 years of age 
o 50 years of age or older 
2.  What is your highest level of nursing education? 
o Diploma     
o Associate  
o Baccalaureate  
o Graduate 
o Doctoral 
3.  Numbers of years employed as a registered nurse? 
o Less than 2 years 
o 3-5 years 
o 5-10 years 
o Greater than 10 years 
4.  Number of years working in a Level III NICU 
o Less than 2 years 
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o 3-5 years 
o 5-10 years 
o Greater than 10 years 
5.  Number of years caring for newborns with NAS 
o Less than 2 years 
o 3-5 years 
o 5-10 years 
o Greater than 10 years 
6.  How strong would you say your moral beliefs influence your patient care? 
o Not at all 
o Minimally 
o Moderately 
o Significantly 
7.  How strong would you say your moral beliefs influence your interactions with parents 
exhibiting high risk behaviors? 
o Not at all 
o Minimally 
o Moderately 
o Significantly 
8.  Are you professionally satisfied when providing care for newborns with Neonatal Abstinence 
Syndrome (NAS)?  Please circle:  Yes     No 
 
  
103 
9.  If you had a choice in assignments in caring for newborns with NAS or a 24 week critically ill 
preterm neonate; you would choose to care for? 
o Newborns with NAS 
o 24 week preterm critically ill neonates 
10.  Should newborns with NAS be cared for in: 
o Well newborn nurseries 
o Neonatal Intensive Care Units 
o Specialized units developed to care for the NAS newborns and parental caregivers 
11.  Please identify one to three reasons below for your choice of responses to questions 9 & 10: 
o _________________________________________________ 
o _________________________________________________ 
o _________________________________________________ 
Thank you for completing the demographic portion of the study.  Please proceed to the 
next section containing the Moral Distress Scale questions and response choices. 
  
104 
Appendix F: Permission to Use MDS-R 
From: Ann B Hamric [mailto:abhamric@vcu.edu]  
Sent: Thursday, February 19, 2015 6:30 PM 
To: Artigas, Valarie 
Cc: Alison Crehore 
Subject: Re: Permission for Moral Distress Scale Usage 
  
Dear Ms. Artigas,  
 
Thank you for your interest in the Moral Distress Scale – Revised (MDS-R).  There are six 
versions of this scale: nurse, physician and other healthcare professional versions for adult 
settings (including ICUs and other inpatient units), and parallel versions for healthcare providers 
in pediatric settings.  The MDS-R shows evidence of reliability and validity, and a publication 
describing the instrument and its testing has been published in the American Journal of 
Bioethics: Primary Research: 
 
Hamric, A.B., Borchers, C.T., & Epstein, E.G. (2012). Development and testing of an instrument 
to measure moral distress in healthcare professionals. AJOB Primary Research, 3(2), pp. 1-9. 
You should read this article before deciding whether the MDS-R will be appropriate for your 
project. 
 
The MDS-R has a unique scoring scheme, designed to give a measure of current level of moral 
distress. Conceptually, items that have never been experienced or are not seen as distressing do 
not contribute to an individual’s level of moral distress.  As noted, the Likert scales for each item 
have been adjusted to 0-4 from Corley’s original 1-7 scoring range.  To generate a composite 
score, the frequency score and intensity (named “level of disturbance”) score for each item 
should be multiplied; note that this results in eliminating items never experienced or not 
distressing from the composite score.  In addition, items rarely experienced or minimally 
distressing have low scores and items experienced frequently and as most distressing have higher 
scores.   Each item product of frequency and intensity will range from 0 to 16.  To obtain a 
composite score of moral distress, these individual item products should be added together.  
Using this scoring scheme allows all items marked as never experienced or not distressing to be 
eliminated from the score, giving a more accurate reflection of actual moral distress.  The 
resulting score based on 21 items will have a range of 0 – 336.  
 
I am happy to grant permission to use any of the MDS-R scales, but require agreement to the 
following condition:  Individuals wishing to use the MDS-R must agree to share their data with 
Drs. Hamric and Corley in an SPSS file in order to further the psychometric testing of the 
instrument. 
 
If you agree to adhere to this condition for use, I am happy to give you permission to use the 
scales.  I have attached the pediatric version of the MDS-R; let me know if you are interested in 
other versions of the instrument. NOTE that there is not a neonatal version of the instrument -- 
you should examine the items carefully to see if they will be appropriate for measuring moral 
distress in your study.  If you decide to change items for particular specialty purposes or for 
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different settings, Dr. Corley and I request that you keep us informed of the changes you make 
and the results you obtain.  
 
Best wishes for success with your research! 
 
********************************************** 
Ann B. Hamric, PhD, RN, FAAN 
Associate Dean of Academic Programs 
Professor, School of Nursing 
Virginia Commonwealth University 
1100 East Leigh Street, Room 4009b 
P.O. Box 980567 
Richmond, VA 23298-0567 
Phone: 804.828.3968 
Fax: 804.827.5334 
abhamric@vcu.edu 
